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Abstract 
Mechanical allodynia is a type of neuropathic pain in which innocuous touch evokes severe pain. 
Despite several years of research, the primary sensory neurons that mediate allodynia still remain 
unidentified. In this study, we demonstrate that a population of low threshold mechanoreceptors 
expressing TrkB mediates the input that produces pain from light touch after nerve injury. Using 
an inducible Cre line driven from the TrkB gene locus, we show that TrkB is expressed in D-
hairs and RA Ab-mechanoreceptors. Ablation of TrkB positive neurons leads to reduction in 
sensitivity to the gentle touch under naïve conditions, and failure to develop mechanical 
allodynia in a nerve injury model of neuropathic pain. Also, selective optogenetic activation of 
these neurons evokes marked nocifensive behavior after nerve injury. Furthermore, we develop a 
phototherapeutic strategy based on the ligand for TrkB to perform ligand-mediated photo-
ablation of TrkB positive afferents. Using this approach we show that selective photo-ablation of 
TrkB afferents in the skin results in a pronounced rescue of mechanical allodynia in multiple 
models of neuropathic pain. We thus identify the peripheral neurons which transmit pain from 
light touch and establish a novel therapeutic strategy for its treatment.   
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Zusammenfassung  
Mechanische Allodynie ist eine Klasse von neuropatischem Schmerz, bei der eine sanfte 
Berührung einen heftigen Schmerz auslöst. Trotz intensiver Forschung konnten bisher die 
primären sensorischen Neuronen, die für die Allodynie verantwortlich sind, nicht identifiziert 
werden. In dieser Studie zeigen wir, dass eine Gruppe von TrkB exprimierenden 
niedrigschwelligen Mechanorezeptoren als Auslöser für den Schmerz durch sanfte Berührung 
nach einer Nervenverletzung verantwortlich sind. Mit Hilfe einer induzierbaren Cre Linie, die 
aus dem TrkB Genlokus abstammt, zeigen wir, dass TrkB im D-Haar und in RA Ab-
Mechanorezeptoren exprimiert wird. Die Entfernung von TrkB-positiven Neuronen führt zu 
einer Reduktion der Sensitivität der sanften Berührung unter naiven Bedingungen und die 
Nerven sind in einem Modell mit einer Nervenverletzung nicht in der Lage, eine mechanische 
Allodynie zu entwickeln. Auch ruft eine selektive optogenetische Aktivierung dieser Neuronen 
ein deutliches nozifensives Verhalten nach einer Nervenverletzung hervor. Des Weiteren 
entwickeln wir eine phototherapeutische Strategie, die auf dem Liganden für TrkB beruht, um 
eine Liganden-abhängige Photoablation von TrkB-positiven afferenten Neuronen durchzuführen. 
Durch diesen Ansatz zeigen wir, dass selektive Photoablation von TrkB afferenten Neuronen in 
der Haut zu einer ausgeprägten Auslösung von mechanischer Allodynie in multiplen Modellen 
von neuropathischen Schmerz führt. Auf diese Weise können wir die peripheren Neuronen 
identifizieren, welche die leichte Berührung in Schmerz verwandeln, und können einen neuen 
therapeutischen Ansatz hierfür entwickeln. 
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2 Introduction 
2.1 Somatosensation  
The ability of organisms to detect and respond to the many forces acting on the body is 
crucial for their interaction with the environment and for survival. Evolutionarily mammals have 
evolved to differentiate between noxious, such as extreme heat or an injury causing stimuli and 
innocuous stimuli, such as a mother’s nurturing caress, feeling a gentle breeze by the sea or 
crawling of an insect on the skin. How this assortment of stimuli is perceived by the body has 
fascinated scientists and philosophers alike for several centuries. The sense of touch was 
described by Aristotle as one of five basic senses along with sight, hearing, taste and smell. The 
dawn of the 17th century saw the postulation of four major theories to describe the perception of 
touch and pain; specificity, intensity, pattern and gate control theories (Perl, 2007, Moayedi and 
Davis, 2013). The specificity theory posits that dedicated pathways carry specific stimuli. For 
example noxious stimuli were carried to the brain by pain-sensing afferents (later termed 
nociceptors) while non-noxious stimuli were encoded by mechanoreceptors (Sherrington, 1903). 
A representation of the connections was provided much earlier by Rene Descartes in his image 
‘concept of pain’ (Perl, 2007). The specificity theory was further strengthened by the discovery 
of cutaneous end organs in the skin like the Meissner’s and Pacinian corpuscles, Merkel cells etc. 
This discovery also led to the fall of the intensity theory, which required a sufficient intensity to 
be reached for a stimulus to feel painful (Dallenbach, 1939). In parallel, the pattern theory was 
proposed to challenge the specificity theory. According to the pattern theory, response to stimuli 
is produced by impulses travelling in varied spatio-temporal pattern. The postulate relies on the 
conduction velocity, adaptation rates and the receptive fields of the primary afferent fibers to 
generate a sensation in the brain (Lele et al., 1954).  
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Finally, the Gate Control theory of pain (GCT) combines the above theories to an extent. First 
proposed by Wall and Melzack in 1965, the GCT is based on the presence of ‘gates’ in dorsal 
horn of the spinal cord which is composed mainly of pain-transmission interneurons. According 
to the theory, noxious stimuli carried by pain transducing fibers open the gate leading to pain 
perception while an innocuous stimulus closes the gate to pain through a series of feed forward 
inhibitory networks (Melzack and Wall, 1965). The GCT shed lights on the plasticity of the 
somatosensory system. Earlier it was assumed that the primary afferents formed a hard-wired 
circuitry. Under this assumption pathological pain states such as that arising due to neuropathic 
pain could not be accounted for. The GCT refutes this concept and provides an alternate circuit 
for conditions of hypersensitivity and also mechanical allodynia.    
2.2 The peripheral nervous system 
The cell bodies of primary afferent fibers located within the Dorsal Root Ganglia are 
pseudo-unipolar neurons containing one axon branching into different regions of the hairy and 
glabrous skin, and a second axon terminating in different laminae of the spinal cord. Cutaneous 
sensory neurons can be grouped into Ab, Ad and C-fibers based on the extent of myelination of 
the nerves, their conduction velocities, adaptation properties and mechanical thresholds (Brown 
and Iggo, 1967, Burgess et al., 1968, Zotterman, 1939). Ab-fibers are thickly myelinated and 
have fast conduction velocities (16-100m/s). Ad-fibers are thinly myelinated and have 
conduction velocities in the range of 5-30m/s and C-fibers are unmyelinated with slow 
conduction velocities (0.2-2m/s). Furthermore, cutaneous fibers can adapt rapidly (RA) or slowly 
(SA) to a constant stimuli (Iggo, 1985). Almost all Ab-fibers and subsets of Ad and C-fibers 
exhibit low mechanical threshold to von-Frey filaments suggesting their role in detecting 
innocuous mechanical stimuli while most Ad and C-fibers have high mechanical thresholds and 
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are believed to detect noxious mechanical or thermal stimuli (Zotterman, 1939, Koerber and 
Woodbury, 2002, Zimmermann et al., 2009).  
 
Figure 1: Schematic of sensory afferents 
A diagram of the somatosensory system showing the heterogeneous group of DRG neurons and 
their axonal projections in the periphery and the spinal cord.  
 
The stimuli transduced from the skin and deep visceral organs terminate in different 
laminae of the dorsal horn of spinal cord which acts as the integration port for the signals. The 
dorsal horn of the spinal cord can be divided into six laminae as described by Rexed using Nissl 
staining on cross sections of the spinal cord (Light and Perl, 1979). Lamina I, the outermost layer 
of the dorsal horn receives inputs largely from pain and heat/cold sensing Ad and C-fiber 
afferents. The lamina II, also referred to as the substantial gelatinosa can be subdivided into two 
regions; lamina IIo and IIi, and receive inputs from neurons carrying information about pain and 
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innocuous touch respectively. Laminae III to VI are mainly innervated by hair follicle afferents 
(mostly Ad and Ab) which form ‘flamed-shaped’ arbors and by specialized touch sensing organs 
in the limbs (Light and Perl, 1979). The different laminae of the dorsal horn are also composed 
of morphologically distinct, locally projecting interneurons. Nearly 30-40% of interneurons in 
the dorsal horn is inhibitory and use GABA and/or glycine as neurotransmitters while the 
remaining interneurons are excitatory and depend on glutamate (Todd, 2010, Zeilhofer et al., 
2012). The dorsal horn also contains many projection neurons that are mainly concentrated 
within lamina I and some as Wide Dynamic Range (WDR) neurons in deep laminae that relay 
information into different regions of the brainstem and the thalamus (Todd, 2010). While how 
different innocuous tactile stimuli are integrated within the spinal cord remains unclear, great 
advancements have been made in understanding how painful stimuli is processed in the dorsal 
horn, especially under chronic pain conditions and this will be discussed in more detail in later 
sections of this thesis.  
The ability of sensory neurons to detect several distinct sensory modalities is attributed to 
the heterogeneity of fiber types. During development, DRG neurons undergo a series of 
diversification events controlled by neurogenin1 and neurogenin2 along with a combination of 
transcription factors (Runx1 and Runx3) (Ma et al., 1999), receptor tyrosine kinases (TrkA, 
TrkB, TrkC and Ret) (Huang and Reichardt, 2003) and neurotrophic growth factors like Nerve 
Growth Factor (NGF), Brain Derived Neurotrophic Factor (BDNF), Neurotrophins NT-3, NT-4 
and the GDNF family of ligands (Ernsberger, 2009) to form different subsets that can be broadly 
categorized as nociceptors, thermo-receptors, mechanoreceptors, proprioceptors and pruriceptors 
(Marmigere and Ernfors, 2007, Liu and Ma, 2011). A more detailed description of 
mechanoreceptors and to an extent about nociceptors will be provided in the next sections.  
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2.3 Nociceptors 
Nociceptors are a class of sensory neurons that are specialized to detect noxious thermal, 
mechanical or chemical stimuli. They make up a majority of small-to-medium sized neurons in 
the DRG and can be either thinly myelinated Ad nociceptors (AM fibers) or unmyelinated C-
fibers (Woolf and Ma, 2007, Basbaum et al., 2009). Anatomically, nociceptive afferents form 
extensive ‘free nerve endings’ in the epidermis of the hairy and the glabrous skin (Zylka et al., 
2005) and terminate within lamina I/IIo of the spinal cord dorsal horn. Most nociceptive neurons 
can detect more than one stimuli (i.e. noxious mechanical and thermal stimuli) making them 
poly-modal in nature (Basbaum et al., 2009, Woolf and Ma, 2007). 
The development of nociceptors depends on a second wave of neurogenesis originating 
from the neural crest tube driven by neurogenin1 (Nng1) (Ma et al., 1999). All developing 
nociceptors express receptor tyrosine kinase, TrkA. Following development, some nociceptors 
lose the expression of TrkA and develop expression of another receptor tyrosine kinase; Ret. At 
this stage, nociceptors can be further segregated into TrkA+ peptidergic or TrkA-/Ret+ non-
peptidergic nociceptors. These two classes of nociceptors can be distinguished by their binding 
to CGRP and/or substance P and isolectin-B4 respectively (Snider and McMahon, 1998, 
Molliver et al., 1997). Fully developed nociceptors also express an array of ion channels that is 
essential for determining the type of noxious stimuli they detect. For example, members of the 
TRP channel (TRPV1, TRPA1, TRPM8 etc.) have been shown to be activated by noxious 
thermal and chemical stimuli (Julius and Basbaum, 2001, Caterina et al., 1997). Similarly, 
nociceptive neurons expressing voltage gated sodium channels like Nav1.7, Nav1.8 (Cox et al., 
2006, Zimmermann et al., 2007), ASIC channels (Lingueglia, 2007) and a newly discovered 
class of Mas-related G protein coupled receptors (MRGPR) have been shown in transducing 
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harmful mechanical pain (Dong et al., 2001, Cavanaugh et al., 2009). Another interesting class of 
nociceptors, called the ‘silent nociceptors’ are unmyelinated neurons that are mechanical 
insensitive under naïve conditions but develop mechanical sensitivity upon injury (Schmidt et al., 
1995). 
2.4 Mechanoreceptors 
Mechanoreceptors constitute a diverse group of neurons that detect innocuous mechanical 
force acting on the skin. Mechanosensitive neurons can be one of two main types, Low-
Threshold Mechanoreceptors (LTMR’s) and High Threshold Mechanoreceptors (HTMR’s), 
depending on the strength of mechanical stimuli they detect (Abraira and Ginty, 2013).  
 
Figure 2: Schematic of cutaneous receptors 
Schematic showing the different types of innervations within the skin. Cutaneous 
mechanoreceptors mainly innervate hair follicles, Merkel cells, Meissner’s 
corpuscles and the Pacinian corpuscles. 
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One of the hallmark features of mechanoreceptors lies in the diversity of skin structures they 
innervate. Mammalian skin can be divided into hairy skin, which contributes to nearly 80% of all 
skin area and the glabrous or non-hairy skin (fig 2).  
2.4.1 Hairy skin mechanoreceptors  
The hairy skin is composed of 3 major hair follicle subtypes: guard, zig-zag and 
awl/auchene hairs which are innervated by one or a combination of Ab, Ad and C-fiber LTMR’s 
in an intricate pattern forming fork-like nerve endings (Hoggan and Hoggan, 1893).   
The most abundant fiber type present in the hairy skin are the C-fiber LTMR’s which 
form longitudinal lanceolate endings associated with Zigzag and Awl/Auchene hair follicles 
which make up 76% and 23% of all hair follicles types in the skin (Li et al., 2011). Although C-
fibers were originally thought to transduce noxious stimuli through their free nerve endings, hair 
follicle C-LTMR’s have been shown to be activated by skin indentation and slow movement 
across the skin associated with tickling or massage-like stimuli (Vrontou et al., 2013). 
Interestingly, psychophysical studies on C-tactile afferents of human suggest their function in 
detecting pleasant mechanical stimuli that controls social and emotional aspects of gentle skin to 
skin contact (McGlone et al., 2014). 
The second major type of fiber innervating hair follicles is the Ad-LTMR or the D-hair 
receptors. D-hairs get their name from the small down hairs present in cats and rabbit (Brown 
and Iggo, 1967). D-hairs have unique physiological properties among all fiber types in that they 
are the most sensitive mechanoreceptor in the skin with the lowest mechanical threshold of 
activation and the largest receptive field in the skin (Lechner and Lewin, 2013). D-hair receptors 
form lanceolate endings associated with almost all Zigzag and Awl/Auchene hairs (Li et al., 
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2011). Recently, it has been shown that D-hairs receive Ad-fiber innervations in a Caudal-to-
Rostral direction suggesting a potential role in detecting movement of hair in one direction 
(Rutlin et al., 2014).  
The third type, Ab-fibers are found in two different areas of the hairy skin. RA Ab-fibers 
are found innervating Guard hair follicles which make up only 1-2% of all hair types (Li et al., 
2011), while SA Ab-fibers form connections with Merkel cells in touch domes of the skin (Iggo 
and Muir, 1969). Although least abundant in the hairy skin, Ab-fibers are predominantly found 
in the glabrous skin. 
2.4.2 Glabrous skin mechanoreceptors             
The glabrous skin contains several specialized mechanosensory end organs like the 
Meissner corpuscles, Pacinian corpuscles, Merkel-cell neurite complexes and Ruffini endings 
(Iggo and Andres, 1982). Each of these end organs receives primary afferent innervations from 
different sub-populations of LTMR’s and are tuned to detect different forces like pressure, 
vibration, skin-indentation, movement of the hair and light touch of the skin.  
Meissner’s corpuscles as described by Georg Meissner in 1852 are located in the dermal 
papillae mainly of the palm and foot (Cauna, 1956). They receive innervations from RA Ab-
fibers and are termed RAI mechanoreceptors. These afferents fire only at the onset and the offset 
of the stimuli. Microstimulation studies of the hand show that Ab-fibers of the Meissner’s 
corpuscles have low threshold of activation, are tuned to frequencies of 10-50Hz and have small 
receptive fields that help detecting ‘flutter’ or similar low frequency vibrations (Talbot et al., 
1968, Pare et al., 2001).  
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Pacinian corpuscles are located in the subcutaneous region of the skin (Zelena, 1978) and 
are characterized by large receptive fields and firing to high frequency vibrations (200-300Hz). 
Pacinian corpuscles receive one Ab-fiber innervation and are generally termed RAII 
mechanoreceptors (Wende et al., 2012b, Fleming et al., 2016). Although the function of these 
corpuscles is not clearly understood, they are believed to sense the texture or dimensions of 
objects through touch (Brisben et al., 1999). 
Merkel cells are specialized keratinocytes that are present in the basal epidermis. They 
receive inputs from Ab-fibers to form Merkel cell-neurite complexes (Halata et al., 2003, 
Maricich et al., 2009). They are usually present in the basal epidermis or as a cluster of cells 
called ‘touch-domes’ often associated with guard hairs (Li et al., 2011). In contrast to Meissner’s 
and Pacinian corpuscles, the afferents that form connections with Merkel cells are SAI-type that 
fire at the onset and remain active throughout the static phase of the stimuli (Carroll, 1998, 
Maricich et al., 2009). Merkel cell-neurite complex forms a ‘two-receptor’ system with the 
Merkel cells and the afferents transducing the static and dynamic stimuli respectively 
contributing to discriminative light touch (Maksimovic et al., 2014, Woo et al., 2014).  
Ruffini endings are corpuscular structures that receive one Ab-fiber innervation 
(Chambers et al., 1972). They are characterized by SAII responses that exhibit firing at regular 
intervals during the static phase as compared to the constant firing of SAI afferents 
(Zimmermann et al., 2009). The presence of Ruffini endings in most mammals is still unclear. 
However, physiological recordings place the corpuscles as stretch detectors.  
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Although electrophysiological properties of cutaneous mechanoreceptors have been 
extensively characterized in cats, rabbits, monkeys, rodents and humans, very little are known 
about the molecular identities of the neurons and their composition. 
2.5 Diversification of mechanoreceptors 
The development of mechanoreceptors is driven by a first wave of neurogenesis controlled 
by neurogenin2 (ngn2) with the expression of one or a combination TrkB, TrkC and Ret (Ma et 
al., 1999). This process can delineated into the early-Ret and the TrkB/TrkC populations 
(Lallemend and Ernfors, 2012). The early-Ret neurons rely on transcription factor MafA for its 
diversification between E10.5-E11.5 (Bourane et al., 2009). By E16.5, 3 different subsets of 
early-Ret can be visualized; Ret+/MafA+, Ret+/MafA+/TrkC+ and Ret+/TrkB+/MafA+/Shox2+ 
(Abdo et al., 2011, Scott et al., 2011). We now know that the Ret+/MafA+ neurons are the Ab-
mechanoreceptors that innervate Meissner’s corpuscles and form lanceolate endings on Guard 
hairs (Bourane et al., 2009) and the Ret+/MafA+/TrkC+ become circumferential Ab-field 
receptors (Bai et al., 2015). It is conceived that the involvement of Shox2 in the 
Ret+/TrkB+/MafA+/Shox2+ population leads to the development of a TrkB+/Ret+ population 
whose function remains unknown (Abdo et al., 2011, Kramer et al., 2006). In parallel, Shox2 
suppresses Runx3 to form TrkB only population that is believed to form lightly myelinated Ad-
fibers (Scott et al., 2011, Li et al., 2011). 
On the other hand, C-fiber LTMR’s develop through two separate diversification events 
with the expression of Ret+/MrgprB4+ and Ret+/TH+/Vglut3+ neurons (Molliver et al., 1997, Liu 
et al., 2008). The development of Vglu3+/TH+ neurons is controlled by Transcription factor 
Runx1 which diversify into TH+ lanceolate endings and Vglut3+ free nerve endings (Lou et al., 
2013). The Ret+/MrgprB4+ neurons diversify in later stages of development with the help of 
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Runx1 which in combination with TrkA controls the segregation of the different Mas related G 
proteins family (Liu and Ma, 2011). The Ret+/MrgprB4+ are believed to diversify only in the 
early postnatal days (Liu et al., 2007).  
In spite of our understanding of the development of different subclasses of mechanoreceptors, 
their role in the behavior of mammals remain poorly understood mainly owing to the lack of 
genetic tools to manipulate these neurons and the lack of differential touch assays.   
2.6 Genetic labelling of mechanoreceptor subtypes 
Alongside their role in development, Ret, TrkA, TrkB and TrkC and their ligands have 
also been used as molecular markers for labelling different sensory neurons. This has been 
demonstrated in a recent study using unbiased single cell sequencing techniques to classify 
sensory neurons into four different mechanoreceptor subtypes (Fig 3)(Usoskin et al., 2015). 
 
Figure 3: Classification of sensory neuron subtypes 
Mechanoreceptors can be broadly classified into 4 distinct subtypes as suggested by 
Usoskin et al., in 2015 using single cell sequencing techniques.  
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Among these, RA-LTMR’s and their dependence on Ret signaling for forming circuits required 
for the perception of touch are the best characterized thus far. Using RetCreERT2 knock-in mice, 
Luo et al., showed that tamoxifen administration at E12.5, marks a population of early-Ret+ in 
adult mice that exhibit features of RA Ab-mechanoreceptors as characterized by the expression 
of NF200, a marker for myelinated sensory neurons and co-receptor GFRa2 (Luo et al., 2009). 
They also show that Ret+ neurons innervated Meissner’s and Pacinian corpuscles, and formed 
longitudinal lanceolate endings around hair follicles. Furthermore, using a WntCre::Retf/f mice, 
they provide proof that Ret expression and Ret-GFRa2 signaling is required only for the survival 
of Pacinian corpuscles and the requirement of TrkB-BDNF signaling for the survival of 
Meissner’s corpuscles and hair follicle endings (Luo et al., 2009). In parallel, using an in-situ 
screen Bourane et al., found transcription factor MafA to be expressed in early-Ret+ neurons. 
MafA+/Ret+/GFRa2+ neurons displayed properties of RA Ab-mechanoreceptors and experiments 
with mutant MafA show that MafA controls the formation of Ret-specific subpopulations. 
However, the function of RA Ab-mechanoreceptors remained unaffected in MafA mutants 
(Bourane et al., 2009). Another candidate transcription factor found in developing sensory 
neurons that has been studied in the formation of Ret+ neurons is c-Maf. c-Maf is co-expressed 
with MafA during development and postnatally. Ab-fiber conduction velocity and firing 
properties of the fibers were disrupted in c-Mafflox/- mice. Morphologically, c-Mafflox/- mice 
displayed reduced NF200+ lanceolate endings and a 75% reduction of Meissner’s corpuscles. 
The strongest effect was a reduction in the quantity of Pacinian corpuscles and a 60% loss of 
axonal innervation of these corpuscles. Also, the authors found a defect in the detection of 
vibration in patients carrying a R288P mutation in c-Maf, without any changes in the tactile 
acuity suggesting a role for c-Maf in maintaining the function of Ret+/MafA+ neurons 
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innervating the Pacinian corpuscles (Bourane et al., 2009, Wende et al., 2012a, Wende et al., 
2012b). Hair follicle innervating Ab-fibers have been found to express Npy2r. Npy2rGFP was 
found in around 6% of all thoracic DRG neurons and co-expressed NF200 and Ret. Skin-nerve 
recordings from these mice displayed RA Ab-fiber activation properties. GFP positive nerves 
were found to form lanceolate endings around guard and awl/auchene hair follicles and also 
innervated Merkel cell touch domes (Li et al., 2011). 
C-fiber LTMR’s can be characterized as Vglut3+/TH+ and MrgprB4+ neurons (Li et al., 
2011, Lou et al., 2013, Vrontou, 2013). Vglut3-GFP is expressed in 10% of all lumbar DRG 
neurons almost all of which are unmyelinated. Skin-nerve recordings show that Vglut3+ neurons 
have slow conducting velocities (~0.58m/s) and displayed properties of C-fiber LTMR’s. 
Behavioral studies on Vglut3-/- mice show significant difference in responses to a tail-clip test 
and tail withdrawal tests suggesting a role in detecting noxious mechanical stimuli (Seal et al., 
2009). However using Vglut3Cre mice, Luo et al., showed that Vglut3 is expressed in 19% of all 
DRG neurons and those Vglut3+ C-fibers can be subdivided into Vglut3+/TH+ and Vglut3+/TH- 
populations. Vglut3+/TH+ neurons were found to express Ret and GFRa2 while they were 
negative for NF200 and other nociceptive markers like isolectin-B4 or CGRP (Lou et al., 2013). 
These TH+ neurons innervate hair follicles forming lanceolate endings around zigzag and 
awl/auchene hairs (Li et al., 2011). The Vglut3+/TH- neurons form free-nerve endings in the 
epidermis of the skin. Selective removal of Vglut3+/TH+ neurons using Vglut3Cre::Runx1f/f 
showed no impairments in mechanical or thermal sensitivities of mice (Lou et al., 2013).  
The second population of C-fibers express Mas related G protein coupled receptor B4 
(MrgprB4). MrgprB4 is expressed in 2% of DRG neurons and are present as arborized free nerve 
endings in the epidermis of the skin along with circular endings around the hair follicles. These 
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arborizations are believed to resemble CT fibers in humans (Liu et al., 2007). GCaMP imaging 
using MrgprB4Cre mice showed responses to brushing the skin using a paint-brush and 
pharmacological activation of MrgprB4+ afferents resulted in a positive reinforcement in a 
conditional place preference test (Vrontou et al., 2013). However electrophysiological proof of 
MrgprB4+ C-LTMR’s is still lacking. 
As mentioned earlier, Ad-LTMR’s constitute one of the most sensitive mechanoreceptor 
subtypes. Although first recorded in cat hindpaw by Iggo and Brown in 1967, the identity of D-
hair mechanoreceptors remained unknown until 15 years back (Brown and Iggo, 1967, Stucky et 
al., 1998). Studies on mice lacking Neurotrophin-4 (NT4-/-) showed reduction in the number of 
innervated D-hairs upon histological analysis of the skin and a severe loss of Ad-fiber firing in 
skin-nerve electrophysiology experiments, while over-expression of NT4 lead to an increase in 
myelinated lanceolate endings (Stucky et al., 1998). Subsequent studies on gene expression in 
NT4-/- mice led to the discovery of a T-type calcium channel (Cav3.2) to be specifically 
expressed in D-hairs which are also believed to account for the sensitivity of these receptors 
(Shin et al., 2003, Wang and Lewin, 2011). Similarly, studies on BDNF deficient mice showed 
reduced mechanical sensitivity of SA-mechanoreceptors (Carroll, 1998). Recently, David Ginty 
and colleagues studied the expression of TrkB in adult DRG neurons and found that in 
TrkBTauEGFP knock-in mice; TrkB was expressed in 7% of adult thoracic DRG neurons. In skin-
nerve electrophysiology, these medium sized neurons exhibited properties of Ad-LTMR like low 
mechanical threshold of activation (<0.07mN), Rapidly Adapting nature and medium conduction 
velocities of approximately 6m/s (Li et al., 2011). They further extrapolated this work to show 
that lanceolate endings of TrkBCreERT2 afferents on zigzag and awl/auchene hairs were 
concentrated on the caudal side of the hairs that are activated upon deflection of hair in the 
25 
 
Caudal-to-Rostral direction and that this direction selective innervation is driven by the 
expression of ligand BDNF on the caudal side of the hairs by epithelial cells during development 
(Rutlin et al., 2014). This suggests a potential role for TrkB+ neurons to detect gentle breeze or 
brushing in a direction specific manner in the hairy skin. Previously, studies using a TrkB-/- mice 
showed a reduction of medium sized DRG neurons by 32% with a parallel reduction in the 
innervations of hair follicles, Meissner’s corpuscles and Merkel cells suggesting TrkB expression 
in other end organs alongside D-hairs (Perez-Pinera et al., 2008). However, the exact function of 
these neurons in the behavior of adult mice remains unknown. 
Finally, the least understood of all mechanosensory neuron subpopulation are the TrkC+ 
cells. Although mainly thought to be Prorioceptive neurons that detect spatial positioning and 
fine limb movement (Marmigere and Ernfors, 2007), a new study showed that TrkC+/Ret+ 
expressing neurons form circumferential endings on hair follicles and belong to a class of Field-
receptors that detect stroking of a large area of skin but not hair deflection like the lanceolate 
endings (Bai et al., 2015).  
Even though the function of each of these mechanosensory subtypes in the behavior of adult 
mice has not been directly studied, vast progress has been made in elucidating several ion 
channels expressed in cutaneous sensory neurons and their involvement in the mechano-
transduction apparatus.  
2.7 Mechano-transductory channels 
2.7.1 Piezo2 
Piezo proteins form a major group of mechanically activated transmembrane proteins as 
shown by in-vitro experiments using Drosophila and mammalian Piezo channels (Kim et al., 
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2012). In-situ hybridization experiments on mouse DRG neurons showed Piezo2 expression in 
around 20% of all cells most of which were mechanosensory NF200+ with some nociceptors 
included and also in the periphery and some internal organs (Coste et al., 2010). Whole-cell 
patch clamp recordings confirmed the requirement of Piezo2 in gating RA mechanical currents. 
A trio of studies using Piezo2GFP and keratinocyte specific Piezo2-cKO reported a reduction in 
the static firing of SA-LTMR’s and in detection of gentle touch response in mice indicating a 
role of Piezo2 in Merkel-cell mechanotrasnduction (Coste et al., 2012, Woo et al., 2014, 
Maksimovic et al., 2014). Piezo2 has been established as the most prominent 
mechanotransductory channel in mice (Ranade et al., 2014). Moreover, mice with conditional 
knock-out of Piezo2 using pvalbCre and HoxB8cre show profound defects in proprioceptive 
behavior like limb position and fine movement (Woo et al., 2015).      
2.7.2 Acid Sensing Ion Channels 
The ASIC’s form a large family of proton-gated ion channels consisting of 7 isoforms 
most of which are expressed in mechanosensory and nociceptive neurons (Lingueglia, 2007, 
Moshourab et al., 2013). ASIC1, ASIC2 and ASIC3 are the best studied in mechanoreceptors 
(Page et al., 2005, Montano et al., 2009). Histological experiments have shown the expression of 
both ASIC2 and ASIC3 in lanceolate endings and nerves innervating Meissner’s corpuscles and 
Merkel cells. Gene knockout experiments in rodents show defects in mechanical sensitivities and 
firing properties of RA-fibers in the skin while the behavioral effects have been very modest in 
knock-out mice (Price et al., 2001, Mogil et al., 2005), thereby questioning the direct effects of 
ASIC’s in mechanotransduction. 
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2.7.3 Transient Receptor Potential channels 
The TRP superfamily makes up the most prevalent family of ion channels expressed in 
sensory neurons of mammals (Damann et al., 2008). Of the six sub-families only 3 (TRPA1, 
TRPV4 and TRPC1) have been associated with in mechanosensation. Defects in the expression 
of TRPV4 affect the detection of noxious mechanical stimuli and causes mechanical 
hypersensitivity to pain (Alessandri-Haber et al., 2004, Suzuki et al., 2003). Studies on TRPA1-/- 
mice have yielded a mixed phenotype where the disrupted sensitivity to mechanical stimuli in 
naïve and pathological states has been in addition to defects in thermal and noxious pain 
sensation (Bautista et al., 2006). TRPC1 deficient mice show reduced action potential firing to 
low threshold mechanical stimuli in SA-Ab and D-hair fibers. Also, TRPC1-/- mice show 
reduced behavioral responses to brushing of the paw using a cotton-swab (Garrison et al., 2012). 
However, TRPC1 has also been found to be expressed in nociceptive neurons suggesting a more 
moderator role for TRP channels in mechanoreceptors rather than a direct gating channel 
(Christensen and Corey, 2007). 
2.7.4 K+ channel family  
Another family of ion-channels that joins the growing list of mechano-transductory 
channels is the K+ channel family (Medhurst et al., 2001). Behavior studies on KCNK2 and 
KCNK4 mutant mice exhibited increased mechanical sensitivity to innocuous stimuli while 
responses to noxious stimuli remained unaffected. KCNK4 has also been shown to be activated 
by membrane stretch. Furthermore, the two channels have been found to act together to set the 
threshold for activation and in regulating the excitability of neurons (Noel et al., 2009, Alloui et 
al., 2006, Bautista et al., 2008). 
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Another voltage-gated K+ channel that is expressed in mechanoreceptors, especially Ab-fibers is 
KCNQ4. First found in cochlear hair cells and connected to hearing loss, KCNQ4 has been 
found to be expressed in Meissner’s corpuscles and in some lanceolate endings on hair follicles. 
Using Kcnq4-/- mice, Heidenreich et al showed that a loss of KCNQ4 leads to better detection of 
low frequency vibration acting on the skin similar to people carrying KCNQ4 mutation whose 
vibration detection thresholds were lower than healthy siblings, thereby suggesting a role for 
KCNQ4 in tuning mechanoreceptors to detect different stimuli (Heidenreich et al., 2011).   
2.7.5 Stomatin 
Stomatin-like protein (SLP3), a mammalian homologue of the C. elegans MEC2 gene has 
been shown to be crucial for touch sensation in mice (Huang et al., 1995). SLP3 mRNA is 
expressed in all DRG neurons and SLP3-/- showed loss of mechanosensitivity in 40% of all 
myelinated mechanoreceptors in addition to a loss in mechanical currents in these neurons. SLP3 
mutant mice also displayed reduced tactile acuity to a two-place texture discrimination test 
making SLP3 an important unit of myelinated mechanoreceptors (Martinez-Salgado et al., 2007, 
Wetzel et al., 2007, Lapatsina et al., 2012). 
2.7.6 aTAT1 
Apart from transmembrane proteins and ion-channels, cytoskeletal proteins have also been 
implicated in mechanosensation. Initially found in a screen of mutant C.elegans insensitive to 
touch, Mec-17, a a-tubulin actetyltransferase has been shown to be important in touch sensation. 
More recent studies on the mammalian orthologue of Mec-17, aTAT1, have demonstrated its 
necessity in transducing mechanical touch and pain (Kalebic et al., 2013).  
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2.8 Neuropathic pain 
To protect the body from tissue damage, it is extremely crucial to detect painful stimuli 
like extreme heat, harmful chemicals, a sharp object or even fractured bones. An inability to 
detect and respond to painful stimuli leads to self-destruction and in some cases can also be fatal. 
This awareness of acute pain is conferred to the body by the action of nociceptors (Woolf and 
Ma, 2007). However disorders of this system can lead to pain being persistent and chronic. The 
cause for such malfunction of the somatosensory system can range from a trauma to the nerve or 
limb, inflammation, spinal cord injury to cancer, diabetes and multiple sclerosis. Neuropathic has 
been redefined as ‘pain that arises as a consequence of a lesion or a disease affecting the 
somatosensory system’ (Treede et al., 2008). This persistent pain has no protective features and 
could manifest as enhanced responses to a normally noxious stimulus (hyperalgesia) or pain 
perception to an innocuous stimuli (allodynia). Clinically, neuropathic pain has become 
bothersome with nearly a fifth of the population suffering from different forms of chronic pain 
(Treede et al., 1992).  
Hyperalgesia can be defined as a lowered threshold for pain, an increased sensitivity to 
pain in response to supra-threshold stimuli and can also occur spontaneously (in the absence of 
any pain evoking stimuli)(Treede et al., 1992). Hyperalgesia can be classified as primary 
(occurring at the site of injury) or secondary (occurring in the areas surrounding the injury) 
(Treede and Magerl, 1995). After nearly 30 years of research it is now generally agreed that 
primary hyperalgesia occurs as a result of sensitization of nociceptive afferents (Campbell et al., 
1988) while secondary hyperalgesia, especially mechanical allodynia is largely associated with 
central changes in the processing of mechanoreceptor input into the spinal cord (Torebjork et al., 
1992).   
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2.8.1 Primary hyperalgesia 
Primary hyperalgesia develops as a result of peripheral sensitization of nociceptive 
afferents and is generally associated with several inflammatory agents that are released at the site 
of an inflammation. The compounds that contribute to what is called an ‘inflammatory soup’ can 
be neurotransmitters, peptides (like CGRP or substance P), neurotrophins, cytokines, chemokines 
etc. These inflammatory agents are believed to act on the receptors on the nerve terminals of Ad 
and/or C-fiber nociceptors altering their thermal and mechanical thresholds and activation 
properties (Basbaum, 1999, Woolf and Ma, 2007, Basbaum et al., 2009). The most extensively 
studied sensitization of nociceptors in hyperalgesia is to thermal stimuli. In-vivo and in-vitro 
studies on mice lacking the TRPV1 receptor show absence of heat hyperalgesia after carrageenan 
induced inflammation models (Davis et al., 2000, Caterina et al., 2000) and that activity of 
TRPV1 can be modulated by several inflammatory agents (Tominaga et al., 1998). Similarly, 
TRPA1-deficient mice show deficits in bradykinin or mustard oil- evoked hypersensitivity 
(Bautista et al., 2006). Though primarily a cold sensor, TRPA1-deficient mice do not show cold 
hypersensitivity. However, genetic ablation of Nav1.8+ cells using a diphtheria toxin receptor 
results in a loss of cold and mechanical hyperalgesia after inflammation (Abrahamsen et al., 
2008). Even though drastic sensitization to mechanical stimuli was not observed in earlier 
studies, Knockout experiments on Nav1.7, Nav1.8 or double KO mice provide evidence for the 
requirement of these channels in mechanical and thermal primary hyperalgesia but not in injury 
driven neuropathic pain or in allodynia (Nassar et al., 2005, Abrahamsen et al., 2008). 
2.8.2 Secondary hyperalgesia and mechanical allodynia 
Secondary hyperalgesia refers to the hypersensitivity that develops in the areas 
surrounding an injury. This increased sensitivity occurs upon application of a static punctate or 
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dynamic mechanical stimulus in a condition termed allodynia but not to heat stimulus (Treede 
and Magerl, 1995). Mechanical allodynia can be defined as ‘pain due to a stimulus that normally 
does not cause pain’ (Treede et al., 2008). Over the past years, understanding the mechanisms 
behind light touch feeling painful has progressed through the discovery of the role of myelinated 
low-threshold mechanoreceptors in allodynia to change in plasticity of pain transmitting neurons 
within the spinal cord. This evolution has involved elegant intra-neural stimulation studies on 
human subjects with nerve-injury or using capsaicin patches to mimic hyperalgesia to show that 
selective blocking of A-fiber nerve conduction eliminated brush evoked allodynia while blocking 
Ad and C fiber nociceptors did not hyperalgesia (Kilo et al., 1994, LaMotte et al., 1992, 
Campbell et al., 1988, Torebjork et al., 1992). The short latency for pain and the lack of 
nociceptor sensitization to mechanical stimuli (LaMotte et al., 1992) confirmed the role of 
myelinated A-fiber mechanoreceptors in mediating allodynia. This subsequently led to the 
hypothesis that allodynia is caused as a result of central sensitization. Alongside, various 
possible mechanisms have been proposed for the development and maintenance of allodynia 
including ectopic transmission between injured and un-injured afferents in its vicinity, alteration 
in gene expression patterns, sprouting of myelinated fibers from lamina III/IV of the spinal cord 
to Lamina I and a disinhibition of inhibitory interneurons in the dorsal horn (Woolf et al., 1992, 
Lolignier et al., 2015, Bridges et al., 2001). 
One of the major challenges in the field has been to identify the neuronal subpopulation 
that engages in allodynia. With developments in genetic labelling techniques, few possible 
candidates have been suggested. Delta opioid receptors (DOR) have been found to be co-
expressed with TrkA, TrkC and Ret in sensory neurons and DOR-null mice exhibit mechanical 
allodynia after injury (Scherrer et al., 2009) and agonist of DOR display anti-allodynic properties 
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in animal models of neuropathic pain (Ossipov et al., 2004). Similarly Mu-opioid receptors 
(MOR) have also been shown in subpopulations of myelinated sensory neurons (Bardoni et al., 
2014). However, both DOR and MOR expression has been found in nociceptors making them 
heterogeneous thereby limiting the ability to study their role in mechanical allodynia. TLR5, an 
immune system receptor was newly identified as a marker of Ab-LTMR’s. Co-application of 
flagellin (a ligand for TLR5) and  QX-314 (a sodium channel blocker) resulted in blockade of 
sodium currents and evoked action potentials specifically in Ab-fibers but not Ad or C-LTMR’s 
in dissociated DRG neurons and also alleviated mechanical allodynia, albeit only for a few hours 
(Xu et al., 2015). Although this represents an interesting target for treatment of neuropathic pain, 
better understanding of the cellular mechanisms of allodynia would help develop long lasting 
recovery.  
In parallel, several mechano-transduction channels, like Piezo2, SLP3 etc. have also been 
associated with mediating allodynia (Wetzel et al., 2007, Ranade et al., 2014, Cox et al., 2006). 
As stated in earlier sections, cutaneous mechanoreceptors can be myelinated Ab, Ad or 
unmyelinated C-fibers. Despite evidences implicating myelinated A-fibers in allodynia, several 
studies have focused on testing the role of C-fiber mechanoreceptors in mediating neuropathic 
pain (Seal et al., 2009, Delfini et al., 2013). This stems from reports suggesting a role for C-
fibers LTMR’s in gentle touch sensation. Knockout of VGLUT3 significantly reduced 
mechanical hypersensitivity that accompanies nerve injury (Seal et al., 2009). However, this 
phenotype was not evident after genetic ablation of Runx1 in VGLUT3 positive neurons, thereby 
affecting their development (Lou et al., 2013). Instead it was proved that transient expression of 
VGLUT3 in Aβ fibres during development and/or expression in the spinal cord is required for 
pain hypersensitivity. Alternatively it has also been shown that genetic ablation of TAFA4, a 
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chemokine like protein that is present in all VGLUT3+ C-fibers led to mechanical and chemical 
hypersensitivity which was reversed upon application of exogenous TAFA4. This study 
concluded that TAFA4 played an inhibitory effect on mechanical nociception that was lost upon 
its ablation (Delfini et al., 2013).  
2.8.3 Central mechanisms of mechanical allodynia 
The difficulty in identifying the neurons mediating allodynia has not affected the 
advancements have been made in understanding the central mechanisms of allodynia. The dorsal 
horn of the spinal cord processes sensory stimuli arising from the periphery using several 
inhibitory and excitatory interneurons that subsequently contact the projection neurons for relay 
into different regions of the brain (Todd, 2010, Prescott et al., 2014). LTMR’s detecting 
innocuous mechanical stimuli terminate onto GABAergic or glycinergic inhibitory interneurons 
within lamina IIi-III while pain sensing neurons synapse onto excitatory PKCg or somatostatin 
interneurons in lamina I-IIo (Braz et al., 2014, Lu et al., 2013, Zeilhofer et al., 2012). A feed 
forward inhibitory control of A-fiber mechanosensitive neurons comprises a crucial component 
of the Gate Control Theory (Melzack and Wall, 1965). Several ground-breaking studies on the 
spinal cord have provided experimental evidence that an injury causes a disinhibition, giving 
mechanosensitive neurons access to Lamina I pain projecting interneurons through a 
polysynaptic circuit composed of SOM+ and SOM+/PKCg+ excitatory interneurons as a 
consequence of which, touch feels painful (Duan et al., 2014). The nature of this disinhibition 
also remains uncertain as of yet with some reports suggesting a demise of GABAergic 
interneurons (Braz et al., 2012) while others report a diminished inhibition (Foster et al., 2015). 
Recently, a population of excitatory interneurons expressing Vglut3 was identified in lamina 
II/III to receive innocuous touch inputs and whose activation leads to persistent mechanical 
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allodynia while its ablation reduced allodynia suggesting the presence of micro-circuits in the 
dorsal horn (Peirs et al., 2015). In addition to interneurons, microglia also plays a crucial 
intermediate role mechanical allodynia. ATP released after nerve injury triggers the activation of 
microglia through the upregulation of P2X4 receptors and the synthesis of BDNF, which then 
acts on its native receptor TrkB in the dorsal horn and reduces GABAergic inhibition via a 
downregulation potassium-chloride exporter (KCC2) (Coull et al., 2003, Coull et al., 2005). This 
recruitment and proliferation of microglia are mediated by the over-expression of macrophage 
colony stimulating factor (CSF1) by injured sensory neurons (Guan et al., 2016). The classical 
scavenger function of microglia also regulates neuropathic pain states. Indeed impairment of 
microglial phagocytosis in the dorsal horn using TMEM16F cKO mice results in mice not 
developing allodynia after injury (Batti et al., 2016), suggesting a more complex role for 
microglia in neuropathic pain states. 
2.9 Treatment of Neuropathic pain 
Hyperalgesia and allodynia can develop as a consequence of diverse pathological 
conditions. This variation, along with different levels of pain among individuals has made 
assessment and diagnosis of pain difficult (Dworkin et al., 2010, Attal and Bouhassira, 2015). A 
number of improved guidelines for the pharmacological treatment of neuropathic pain are being 
proposed with time (Finnerup et al., 2015). Currently according to the IASP, there are three lines 
of medication; the first line of treatment suggests the use of tricyclic antidepressants (TCA), 
serotonin nor-epinephrine reuptake inhibitors (eg. Duloxetine and venlafaxine) and inhibitors of 
voltage gated calcium channels (like Gabapentin, Pregablin etc.) (Dworkin et al., 2007, Li et al., 
2006). The second line of treatment recommends opioid analgesics like morphine and oxycodone 
or mild cannabinoids (Raja et al., 2002). The third line prescribes stronger dugs and is restricted 
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to patients who are non-responsive to first and second line drugs (Dworkin et al., 2010). 
However, each of above medications comes with adverse side effects which are worrisome on its 
own. Studies in rodents and humans have showed elevated levels of NGF upon inflammation and 
in conditions of arthritis, headaches etc. (Rittner et al., 2008). In parallel, local or systemic 
application of NGF has been implicated in elevated pain states suggesting a critical role for NGF 
under inflammatory states (Hefti et al., 2006). This led to the development of therapeutic targets 
to reduce or block the activation of NGF, the most common of which is Tanezumab (Pfizer), a 
monoclonal antibody against NGF. The use of anti-NGF in pain pharmacotherapy has proven to 
be reasonably efficient in many clinical trials (Schnitzer et al., 2015, Chang et al., 2016). 
Alongside topical application of 5% lidocaine (Wasner et al., 2005) or high-concentration 
capsaicin patches are currently being tested in Randomized Clinical trials (RCT) (Nolano et al., 
1999). The involvement of Nav1.7 and Nav1.8 in enhanced pain states are currently being the 
basis for the development of antagonists of these voltage-gated sodium channels (Minett et al., 
2014, Nassar et al., 2004). Despite the progress, development of better drug targets will be 
facilitated with a better knowledge on the neurons mediating allodynia. 
2.10 Mouse models of neuropathic pain 
Taking into consideration different pathological conditions that can lead up to neuropathic 
pain, different mouse models have been developed to serve as mechanism-based experimental 
tools. Many of the current models make use of an alteration to the sciatic nerve thereby affecting 
the hind-paw. Below mentioned are few of the common models of neuropathic pain in mice.  
2.10.1 Sciatic nerve transection  
This is the oldest model used in the study of neuropathic pain and requires the complete 
transection of the sciatic nerve near the thigh followed by ligation of the nerves above the area of 
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transection (Wall et al., 1979). Because of the spontaneous pain that develops upon injury and 
the frequent self-mutilation observed in many cases, this model is less frequently used. 
2.10.2 Partial nerve ligation (PNL) 
The PNL model is performed by a tight ligation around 35-50% of the exposed sciatic 
nerve leaving the rest of the nerve uninjured. This causes spontaneous-pain, hyperalgesia and 
mechanical allodynia 1 week after the ligation. This model has also been shown to affect a large 
mixture of L4-L5 DRG neurons (Seltzer et al., 1990). 
2.10.3 Chronic constriction injury (CCI) 
The CCI model also involves loose ligation of the sciatic nerve at the mid-thigh leading 
to hyperalgesia to thermal stimuli and allodynia to mechanical stimuli. This model is commonly 
used for its easy reproducibility and has also been performed on the trigeminal ganglia to 
produce trigeminal neuralgia. It mainly affects myelinated fibers corresponding to 30% of all 
DRG neurons. This model however involves an inflammatory component to it (Bennett and Xie, 
1988). 
2.10.4 Spared nerve injury (SNI) 
In the SNI model of neuropathic pain, two (tibial and common peronial) of the three 
branches of the sciatic nerve is ligated and axotomized, leaving the third branch (Sural) intact 
(Decosterd and Woolf, 2000). This results in a hypersensitivity of the sural nerve innervating 
area of the hind paw. Thermal and mechanical hyperalgesia and allodynia develops three days 
following the injury and is long lasting. This model is independent to inflammatory pain and is 
described to be the closest representation of clinically tested neuropathic pain (Pertin et al., 
2012). 
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2.10.5 Spinal nerve ligation 
In addition to peripheral nerve ligation, intentional manipulations of the spinal nerves 
have also been tested. In this model, L5 and L6 spinal nerves are identified and ligated to the 
distal part of the DRG. This produces allodynia and hyperalgesia that lasts for 10 weeks post 
injury (Kim and Chung, 1992).  
2.10.6 Inflammatory pain 
A majority of neuropathic pain is caused by an inflammation to the tissue. Several 
models of inflammatory pain have thus been developed. This comprises injection of pro-
inflammatory agents locally into the paw to facilitate behavioral testing. Such agents can be 
zymosan, Complete Freund’s Agent (CFA), carrageenan, formalin etc (Eliav et al., 1999).    
2.10.7 Diabetic neuropathy 
Diabetic peripheral neuropathy is one of the many complications of diabetes that is 
characterized by progressive degeneration of nerves leading to loss of tactile sensation. Even 
though the mechanism behind diabetic neuropathy remains unclear, mice models to study this 
condition have been developed. The most common of which is ablation of pancreatic b-cells by 
injection of streptozotocin (STZ). Administration of a single high dose (SHD) or multiple low 
doses (MLD) of STZ leads to development of type 1 diabetes and subsequent peripheral 
neuropathy that manifests as bilateral thermal hyperalgesia and mechanical allodynia (O'Brien et 
al., 2014, Murakami et al., 2013).  
2.10.8 Drug-induced neuropathy  
Peripheral neuropathy is also a common side-effect of medication which begins a few 
weeks after initiation of medication and can last for weeks after thereafter. One such medication 
38 
 
induced neuropathic pain is seen after chemotherapy. Some of the chemotherapeutic agents that 
can cause dose-dependent neuropathy (as also seen in animal models) are vincristine, paclitaxel 
and cisplatin (Quasthoff and Hartung, 2002). 
These models of neuropathic pain cause diverse types of primary and secondary 
hyperalgesia and therefore require different types of behavioral test to assay pain. For example 
the most commonly used method to test punctate primary hyperalgesia and allodynia is using 
von-Frey filaments (Chaplan et al., 1994). These are fibers of different diameters that can apply a 
particular force to the skin. Dynamic allodynia are generally tested using paint-brush or cotton 
swab (Garrison et al., 2012) while thermal hyperalgesia are assayed using a hot/cold plate test, 
radiant heat test, Randall-Selitto or an acetone drop test (Brenner et al., 2012). Most of these tests 
will be described in detail in the ‘Methods’ section.  
2.11 TrkB and BDNF: involvement in neuropathic pain 
Neurotrophins and their related receptor tyrosine kinases (Trk’s) are well characterized in 
the development, diversification and survival of DRG neurons. Most of the neurotrophins and 
their receptors also play important roles in pain transmission. In the case of BDNF and its 
cognate receptor TrkB, much of the focus has been confined to the spinal cord and supra-spinal 
regions. Going in line with evidences of exogenous NGF causing thermal and mechanical 
hyperalgesia in rats after inflammation or nerve injury (Woolf et al., 1994, Woolf, 1996), 
intraplantar injections of a high dose of BDNF only produced a marginal thermal hyperalgesia 
which was short-lived compared to NGF or NT-4 under naïve conditions (Shu et al., 1999). 
However, repeated injections of BDNF into the DRG caused after injury increased allodynia 
which was re-attenuated upon injection of anti-BDNF antibodies (Zhou et al., 2000). 
Interestingly, levels TrkB mRNA is also upregulated following peripheral nerve injury (Ernfors 
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et al., 1993). Furthermore, TrkB-BDNF signaling within the spinal cord dorsal horn has been 
implicated in the induction and maintenance of neuropathic pain states (Wang et al., 2009). 
Whether the pre-synaptic TrkB positive afferents also contribute to this state is yet to be 
determined.  
2.12 General aims 
In this study we plan, 
1. To elucidate the role of TrkB+ neurons in the behavior of mice 
2. To test the contribution of TrkB+ neurons to mechanical allodynia 
3. To develop potential therapeutic strategies to target TrkB afferents in the skin      
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3 Materials and methods 
3.1 Generation of TrkBCreERT2 mice 
A bacterial artificial chromosome (BAC) containing the TrkB mouse locus was obtained 
from SourceBioscience (RP23-391J8). Individual BAC clones were then screened and 
electroporated with a plasmid conferring competence for lambda RedET mediated 
recombineering. A modified CreERT2-pA-Frt-Ampicillin-Frt cassette was inserted into the ATG 
of trkB, deleting the entire coding region of exon 2 by homologous recombination using the 
following primers: homology to CreERT2: gacgcctggctcagcgtagggacacgca 
ctccgactgactggcactggcagctcgggatgtccaatttactga and homology to FAF: cccaaacatac 
acctgcctgattcctgaggtggggacaggagaaaaagtaaaaggaactcacgccctgatagacggtttttcgccctttgacgttgg. The  
identity of the clones were confirmed by PCR and full length sequencing of the inserted cassette, 
and the ampicillin cassette was removed using bacterial Flp. Purified BAC DNA was then 
dissolved into Endotoxin-free TE and injected into pronuclei derived from the hybrid B6D2F1/N 
strain (Charles River Laboratories) or prepared for intracytoplasmic sperm injection (ICSI) as 
previously described. Both methods were successful and produced offspring. The genotype of 
mice was determined by performing PCR using the following primers: gcactgatttcgaccaggtt 
(fwd) and gagtcatccttagcgccgta (rev), yielding products of 408bp.  
3.2 Generation of AvilmCherrymice 
The AvilhM3Dq-mCherry line was obtained by a knock-in of a Lox-STOP-Lox-hM3Dq-
mCherry cassette into the Advilin locus, to replace exon 2 and 66bp upstream. The targeting 
construct was transfected into A9 ESC’s. Individual ESC clones were screened to identify 
homologous recombination. Southern blots were performed as described previously (Stantcheva 
et al., 2016). DNA was digested with PstI and HindIII and hybridized with 5’ or 3’ probe, 
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respectively. We obtained 9600bp (wild-type)- and 6300bp (targeted) DNA fragments by using 
the 5’ probe and 7100bp (wild-type)- and 6100bp (targeted) DNA fragments by using the 3’ 
probe. Positive clones were injected into 8-cell stage embryos to generate heterozygous mice for 
the targeted allele. To determine the genotype, PCR were performed using the following primer 
pairs: gccccgtaatgcagaagaag (fwd), gtgtagtcctcgttgtggga (rev).   
3.3 AviliDTR mice 
For diphtheria toxin mediated ablation, AviliDTR mice as described previously (Stantcheva 
et al., 2016) were crossed to TrkBCreERT2 to generate TrkBCreERT2::AviliDTR heterozygous mice. 
Littermates lacking the Cre (referred to as AviliDTR) were used as controls. For optogenetic 
activation using channelrhodopsin, TrkBCreERT2 were crossed to Rosa26ChR2-YFP mice to generate 
TrkBCreERT2::Rosa26ChR2-YFP mice.  
All mice were housed in the EMBL, Mouse Biology Unit, Monterotondo according to the Italian 
legislation (Art. 9, 27. Jan 1992, no 116) under license from the Italian Ministry of Health, and in 
compliance with the ARRIVE guidelines. (Note: the above mentioned mouse lines were 
generated by the Heppenstall lab before my arrival at EMBL, Monterotondo).  
3.4 Tamoxifen treatment 
To induce efficient Cre recombination, adult TrkBCreERT2 mice (6-8 weeks of age) were 
injected intraperitoneally with 75mg/kg of body weight of Tamoxifen (Sigma Aldrich, T5648) in 
sunflower seed oil (Sigma Aldrich, S5007) for 5 consecutive days. Mice were then used for 
experiments 5 days after the final injection.  
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3.5 Immunofluorescence 
DRG were extracted from adult mice and fixed with 4% PFA for 2 hours or overnight at 
4oC. Tissues were embedded in 12% bovine gelatin (Sigma Aldrich, G9391) and sectioned at 
50mm. Sections were then treated with cold 50% ethanol for 30 minutes and incubated with 
blocking solution containing 5% Serum (goat or donkey) and 0.01% Tween-20 in PBS for 30 
minutes and subsequently with one or more primary antibodies in blocking solution overnight at 
4oC. Secondary antibodies were added in blocking solution for 1-2 hours and the slides were 
mounted with prolong gold (Invitrogen, P36930). 
To determine the central projections of TrkB+ neurons, lumbar spinal cord was dissected 
from mice and fixed with 4% PFA for 2 hours or overnight at 4oC. Small pieces of the spinal 
cord were then cryopreserved in 30% sucrose (in PBS) overnight and embedded in Tissue-Tek 
O.C.T compound. 40mm cross sections of the tissue were cut using a cryostat (Leica, CM3050S) 
and stained as described above. In certain cases, an extra signal enhancement step was used by 
incubating sections with a biotinylated anti-rabbit or anti-goat antibody overnight at 4oC 
followed by incubation with streptavidin-conjugated secondary antibody for 1 hour at 4oC.    
For SNAP-tag labeling of the peripheral afferents, the back skin and the paw of 
TrkBCreERT2::Rosa26SnapCaaX mice were injected intradermally with 10mM of Snap Cell TMR-Star 
(New England Bioloabs, S9105S) (Yang et al., 2015). The skin was dissected after 6 hours and 
fixed with 4% PFA overnight. The tissues were then cryoprotected in 30% sucrose overnight at 
4oC and embedded in Tissue-Tek O.C.T compound. 40mm thick sections of the hairy skin and 
20mm sections of the glabrous skin were cut using a cryostat (Leica, CM3050S) and stained with 
one or more antibodies as described above. 
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For human DRG/skin staining, frozen DRG’s were obtained from the National Disease 
Research Interchange (NDRI, USA). Tissue was sectioned at 20mm using a cryostat. Sections 
were then dried, post-fixed with 4% PFA and immunostained as mentioned above. Primary and 
secondary antibodies were incubated in a solution containing 2% BSA (wt/vol) and 0.01% 
Tween-20 in PBS. Fresh skin from the palm was SNAP frozen in Tissue Tek O.C.T compound, 
sectioned at 20mm. Sections were then dried and post-fixed. Protocols similar to DRG were used 
for Meissner’s corpuscles staining.  
The following primary antibodies were used:  
Table 1: List of antibodies used 
Antibody Concentration  Supplier/catalog.  
Rabbit anti-RFP 1:200 Rockland, 600-401-379 
Mouse anti-NF200 1:500 Sigma Aldrich, N0142 
Mouse anti-CGRP 1:500 Rockland, 200-301-D15 
Isolectin GS-B4-biotin XX- conjugate 1:100 Invitrogen I21414 
Rabbit anti-TH 1:1000 Millipore, AB152 
Rabbit anti-PGP9.5 1:200 Dako, Z5116 
Rabbit anti-S100 1:200 Dako, Z0311 
Goat anti-Human HB-EGF 1:50 R&D systems, AF-259-NA 
Rabbit anti-cFos 1:1000 Santa Cruz, Sc-52 
Rabbit anti-TrkB 1:200 ThermoFisher PA5-34026 
Rabbit anti-Ret 1:100 Abcam ab134100 
Mouse anti-TrkA 1:100 ThermoFisher MA5-15509  
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All Alexa conjugated secondary antibodies were used at 1:1000 concentration and streptavidin 
conjugated antibodies were used at 1:600 concentration. All images were taken with a Leica SP5 
Confocal microscope and analyzed in ImageJ. 
3.6 In-situ Hybridization  
DRG were dissected from TrkBCreERT2 mice and postfixed overnight in 4% PFA at 4oC and 
cryoprotected in 30% sucrose solution overnight at 4oC. Tissues were then embedded in tissue 
Tek O.C.T compound and 10mm sections were cut using a cryostat. In-situ hybridization was 
performed as previously described (Mirabeau et al., 2007) using a riboprobe generated from a 
cDNA template (Klein et al., 1989). Briefly, sections were digested for 6 minutes with proteinase 
K, acetylated, and hybridized with the either sense or antisense probes in a solution containing 
50% formamide, 5X SSC, 5x Denhardt’s solution, 500 mg/ml salmon sperm DNA and 250 mg/ml 
tRNA overnight at 56oC.  Tissues were then washed post-hybridization with 50% formamide, 2X 
SSC, then with 0.5X SSC at 56oC and finally with 2X SSC at ambient temperature. Sections 
were blocked and incubated overnight with anti-digoxigenin-AP (Roche; at 1:1000). Signal 
detection was done using NBT/BCIP substrate. 
3.7 Ex-vivo skin nerve preparation 
The skin-nerve electrophysiology was performed in collaboration with Francisco Taberner 
at the University of Heidelberg using a preparation previously described (Zimmermann et al., 
2009). In brief 8-16 weeks old mice were euthanatized with CO2. The skin of the hind limb was 
dissected and placed corium side up in a bath chamber filled with 32ºC-warm synthetic 
interstitial fluid (108 mM NaCl, 3.5 mM KCl, 0.7mM MgSO4, 26mM NaHCO3, 1.7mM 
NaH2PO4, 1.5mM CaCl2, 9.5mM sodium gluconate, 5.5mM glucose and 7.5mM sucrose at a pH 
of 7.4). The nerves were teased into thin bundles and laid on the recording electrode connected to 
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a Neurolog extracellular recording amplifier (Digitimer, modules NL104, NL125/NL126). 
Different regions of the skin were stimulated mechanically using a glass rod to locate single fiber 
units. A Powerlab 2 4SP system and Labchart 7.1 software (AD Instruments) was used to 
analyse the data and the units were classified according to their conduction velocity, von Frey 
hair thresholds and adaptation properties to suprathreshold stimuli. Further characterization with 
ramp-and-hold mechanical stimulation was achieved with a computer-controlled nanomotor® 
(Kleindieck) which allowed for simultaneous recording of electrophysiological and stimulation 
data. For light stimulation of ChR2 expressing nerve fibers, blue-light pulses from a laser (at 
470nm) were focused on discrete spots by coupling the light guide (FG910UEC, Thorlabs) to a 
20x microscope objective using a custom-made adapter. The different light-pulse durations and 
frequencies were generated by the built-in stimulator function of LabChart 7.1 and 
simultaneously recorded. The light intensities were assessed with a powermeter (PM100D, 
Thorlabs). 
3.8 Diphtheria toxin injection 
TrkBCreERT2::AviliDTR mice were injected intraperitoneally with 40mg/kg of diphtheria toxin 
(Sigma, D0564) twice separated by a gap of 72 hours between the two injections. Behavioral 
tests were performed 7 days after the final DTX injection. All mice received diphtheria toxin 
injections. The weight and the condition of mice were monitored during the injection period.  
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3.9 Behavioral testing 
All behavior experiments were performed on adult male mice (>6 weeks of age). For 
controls, littermates without the Cre were used. The experimenter was always blind to the 
genotype of the mice. 
3.9.1 Acetone drop test 
The acetone drop test was used for testing the effect of evaporative cooling on the 
glabrous skin. Mice were habituated for 30 minutes on an elevated platform with mesh flooring. 
A single drop of cold acetone was sprayed onto to the plantar side of the hindpaw of mice using 
a blunt syringe without touching the paw of the mice (Choi et al., 1994). The behavioral 
responses were scored according to the following scheme: 0=no response, 1=paw withdrawal or 
a single flick, 2=repeated flicking of the paw and 3=licking of the paw. The test was repeated 5 
times by alternating the paw and mice between trials. 
3.9.2 Hot plate test 
To measure responses to noxious heat, a hot plate (Ugo Basile, 35150) was preset to 
52oC. Mice were placed on top of the plate individually and the latency to response as observed 
by flicking or licking of the hindpaw was noted. A cutoff of 30 seconds was set in order to avoid 
injury to the mice. All experiments were video recorded. 
3.9.3 Grip strength test 
The grip strength test was performed to test the ability of mice to grip a metal grid 
(Bioseb; BIO-GS3). Mice were placed on a metal grid with all 4 paws touching the grid. The tail 
of the mice was gently pulled and the force at which the mice first let go of the grid was 
measured. The test was repeated 5 times with a 30 second interval between trials.   
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3.9.4 Pin-prick test 
The plantar side of the hindpaw was gently poked using an insect pin glued onto a 1g 
von-Frey filament without penetrating the skin. The responses, as observed by either an 
immediate flicking or licking of the paw were noted for 10 trials with an interval of 1 minute 
between the trials. 
3.9.5 Tape-test 
Mice were habituated to a plexiglass chamber for 15 minutes. A 3cm by 1cm piece of 
adhesive tape (Identi tape) was applied along the back of the mice. Responses were quantified as 
an attempt to remove the tape by shaking, scratching or biting of the tape over a 5 minute period 
(Woo et al., 2014). 
3.9.6 Cotton swab test 
Mice were placed on an elevated platform with a mesh floor and habituated for 30 
minutes. A cotton bud was ‘puffed-out’ to about 3 times its original size. The hindpaw of mice 
were then brushed using this cotton swab in the heel-to-toe direction and the frequency of 
responses were noted (Garrison et al., 2012). The trials were repeated 10 times alternating 
between paws with an interval of 1 minute between trials. 
3.9.7 Von Frey test 
For the von Frey test, mice were habituated on an elevated platform with a mesh floor for 
30 minutes. The plantar side of the hindpaw was stimulated with calibrated von-Frey filaments 
(North coast medical, NC12775-99). The 50% paw withdrawal thresholds were calculated using 
the Up-Down method (Chaplan et al., 1994). In this method, the paw of mice was stimulated by 
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a particular filament. A positive response to the filament lead to testing using a lower filament 
while a negative response to a filament lead to using a higher filament.  
Post SNI, von Frey testing was confined to the sural nerve innervating region of the paw. 
3.9.8 Dynamic brush test 
To measure dynamic allodynia, the plantar hindpaw was stimulated by stroking using a 
paintbrush in the heel-to-toe direction. The responses were scored as described by Duan et.,al 
(Duan et al., 2014). For each test under baseline conditions, 0= no response, 1= paw withdrawal, 
2= flicking of the paw and 3 =licking of the paw. After injury responses were quantified: 0=brief 
withdrawal, 1=prolonged paw withdrawal toward the body, 2=repeated flicking or flinching of 
the affected leg, 3= licking of the paw.  
3.10 Models of neuropathic pain 
3.10.1 Spared nerve injury model 
The spared nerve injury (SNI) was performed as described by Pertin et al (Pertin et al., 
2012). Adult mice were anesthetized using 2.5% isoflurane. The sciatic nerve near the thigh 
region was exposed; the common peroneal and tibial nerves were ligated using a suture thread 
and cut, leaving the sural nerve intact leading to hypersensitivity of the sural nerve innervating 
region of the paw. Behavioral testing was performed starting from 3 days after injury. 
3.10.2 CFA model  
For the inflammatory model of neuropathic pain, the hindpaw of mice was injected with 
20ul of CFA (Sigma Aldrich, F5881). Behavioral tests were performed 24 hours and 48 hours 
after inflammation. 
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3.10.3 Chemotherapy induced neuropathic pain 
To mimic chemotherapy induced neuropathic pain, wildtype C57BL6 mice were injected 
with 1mg/kg of Paclitaxel (Sigma Aldrich, T7191) intraperitoneally for 4 alternate days. Mice 
develop bilateral mechanical allodynia 1 week after the final injection.     
3.10.4 Diabetes induced peripheral neuropathy 
To induce diabetic neuropathy, wildtype C57BL6 mice were injected systemically with 
180mg/kg of Streptozotocin (STZ, Sigma Aldrich S0130) in 0.05M citrate buffer (pH 4.5). This 
single high dose of STZ leads to the development of Type 1 diabetes mellitus within 3 days of 
administration. Mice with blood-glucose levels greater than 350mg/dL were considered diabetic. 
The health of the mice especially the blood-glucose levels were monitored regularly using the 
ACCU-CHEK glucose sticks (Aviva) and maintained between 350-400mg/dL by administration 
of insulin (Caninsulin 40U/ml MSD animal health) as per Table 2. 4 weeks after the onset of 
diabetes, mice develop mechanical hypersensitivity. Behavior experiments to test allodynia were 
carried out as mentioned earlier.   
 
 
Table 2: Insulin dosage to maintain blood-glucose levels 
Blood-glucose levels (mg/dL) Insulin dosage (Units) 
375-425 2U 
425-500 3U 
500-600 4U 
>600 5U 
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3.11 Light activation using channelrhodopsin 
Optogenetic stimulation of the paw was performed using 470nm Blue DPSS laser (SLOC 
CO., Ltd; BL473T8) coupled to a powerlab source (Powerlab 4SP) to generate light pulses. A 
fiber optic cable (0.93NA, SLOC CO., Ltd; FC-200-10-PC) was used to deliver 5-10ms pulses of 
blue light (15Hz) onto the plantar hindpaw of mice. Paw withdrawal to light application was 
considered as a positive response. In all experiments, ipsilateral and contralateral paws of 
TrkBCreERT2::Rosa26ChR2-YFP were tested along with littermate controls (referred to as Rosa26ChR2-
YFP). 
3.12 C-fos labelling of the spinal cord 
For c-Fos labelling of the spinal cord, TrkBCreERT2::Rosa26ChR2 mice were exposed to 
optogenetic stimulation of the injured (ipsilateral) and contralateral paw with a 15Hz blue laser 
light (473nm) for 1 minute. Mice were sacrificed and the lumbar spinal cord was removed and 
fixed with 4% PFA overnight at 4oC. Tissues were then cryoprotected in 30% sucrose and 
embedded in Tissue-Tek O.C.T compound. 40mm sections of the spinal cord were cut using a 
cryostat. The sections were then treated with cold 50% EtOH for 30 minutes followed by 
blocking in a solution containing 10% normal goat serum in PBS with 0.01% Tween20 for 30 
minutes. Sections were then incubated with primary antibodies in blocking solution overnight at 
4oC followed by incubation with secondary antibody for 1 hour in the blocking solution.  
All sections were imaged using Leica SP5 Confocal microscope. The numbers of C-fos positive 
cells in each lamina of the ipsilateral and contralateral sides of the dorsal horn were counted 
using imaris software. 
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3.13 Production of recombinant BDNFSNAP  
cDNAs encoding for the murine BDNF and SNAP proteins including a C-terminal poly-
Histidine Tag (His6) inserted for purification purposes were cloned into the pMP-PB vector as a 
fusion protein (Matasci et al., 2011). Protein expression was carried out using Chinese hamster 
ovary (CHO) cells as described by Balasubramanian et al., (Balasubramanian et al., 2015). 
Secreted BDNFSNAP was purified from cell medium using a Ni-NTA resin (Qiagen, #30210) and 
eluted with an excess of imidazole. Eluted fractions were then pooled, concentrated and stored 
for further analysis. (Produced by David Hacker, Laurance Durrer and Soraya Quinche of the 
Protein expression facility at the EPFL, Lausanne.) 
3.14 Synthesis of BG-IR700 
3mg of IRDye®700DX N-hydroxysuccinimide ester fluorophore (LI-COR Biosciences 
GmbH, Bad Homburg, Germany) were dissolved in 150ul DMSO and treated with 1.5mg BG-
PEG11-NH2[add reference below] and 5ul diisopropylethylamine. After 1h, the product BG-
PEG11-IRDye®700DX was  purified by HPLC using a Waters Sunfire Prep C18 OBD 5uM; 19 
x 150 mm column using 0.1M triethylammonium acetate (TEAA)] (pH 7.0) and 0.1M TEAA in 
water/acetonitrile 3:7 (pH 7.0) as mobile phases A and B, respectively. A linear gradient from 
100% A to 100% B within 30 minutes was used. The fractions containing the product were 
lyophilized (Brun et al., 2009). (Produced by Ahmad Fawzi Hussain, Stefan Barth at Aachen and 
Luc Reymond at EPFL, Lausanne.) 
3.15 In-vitro labeling of BDNFSNAP 
3.15.1 HEK293T labeling 
HEK293T cells were transfected with a combination of 0.125µg trkB/trkA/trkC in 
pcDNA plasmid and 0.125µg p75NTR (all gifts from Moses Chao, Addgene plasmid #24088, 
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#24089, #24093 and #24091 respectively) using Lipofectamine 2000 (Invitrogen, 11668-019) in 
a medium containing DMEM (Gibco, 41966-029), 10% FBS, 1% penicillin/streptomycin. Cells 
were incubated in serum-free medium for 1 hour before labelling. 0.1mM BDNFSNAP was 
coupled to 0.3mM of Snap-surface 647 (New England Biolabs, S9136S) for 1 hour at 37oC and 
applied onto cells for 15 minutes at 4oC. The cells were imaged using a Zeiss AxioObserver A1 
microscope.  
3.15.2 DRG labelling 
DRG from TrkBCreERT2::Rosa26tdRFP mice were dissected in PBS and treated with 1mg/ml 
collagenase IV (Sigma Aldrich, C5138) and 0,05% Trypsin (Gibco, 25300-054) for 25 minutes 
each at 37oC. Cells were then filtered through 100mm cup filcons (BD biosciences, 340629) and 
suspended in medium containing DMEM (Gibco, 41966-029), 10% heat inactivated Fetal 
Bovine Serum (PAA, A15101), 0.8% Glucose and 100U of Penicillin/Streptomycin (Gibco, 
15140-122). Dissociated cells were plated onto glass coverslips treated with Poly-L-lysine and 
stored at 37oC (Stantcheva et al., 2016). An equimolar concentration of BDNFSNAP was coupled 
to a mixture of Snap-Biotin (New England Biolabs, S9110S) and QD655 quantum dots 
(Invitrogen, Q10121MP) at 37oC for 30 minutes. The above mixture was applied onto cells for 5 
minutes at 37oC and imaged using a Zeiss AxioObserver A1 microscope. 
3.16 In-vitro photo-ablation 
HEK293T cells transfected with TrkB (as described above) were incubated with a mixture 
of 1mM BDNFSNAP and 3mM BG-IR700 for 30 minutes at 37oC. Cells were then exposed to near 
infra-red light (680nm) illuminated at 40J/cm2 for 2 minutes. Cells were stained with Propidium 
iodide (eBioscience; 00-6990-50) 24 hours after light exposure to assess cellular apoptosis. Non-
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transfected HEK293T cells with BDNFSNAP-IR700 and transfected cells with IR700 alone were 
used as controls.  
3.17 In-vivo photo-ablation 
The left hindpaw of non-transgenic C57BL6 mice were injected with BDNFSNAP coupled 
to BG-IR700 in a 1:3 ratio. 15-20 minutes after the injection, near infra-red laser light (650nm) at 
120-150J/cm2 or 550-600J/cm2 was applied onto the paw of the mice for different time periods. 
This regime was repeated for 3 consecutive days. Behavioral tests were performed 1-3 days after 
the final treatment. For rescue experiments, neuropathic pain was first induced in C57BL6 mice 
using one of the models described above. Photo-treatment with BDNFSNAP-IR700 was performed 
on the 5th, 6th and 7th days after SNI.  
3.18 Statistical analysis 
All statistical data are presented as Standard error of the mean (SEM) along with the 
number of samples analysed (n). Student’s t-test and/or 2-way Repeated measures ANOVA were 
used and p<0.05 was considered statistically significant.  
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4 Results 
4.1 Molecular characterization of TrkB+ sensory neurons in adult mice 
4.1.1 TrkB expression in the DRG 
In order to visualize the expression pattern of TrkB in the DRG, we generated 
TrkBCreERT2::Rosa26RFP reporter mice. Upon administration of 75mg/kg of tamoxifen for 5 
consecutive days, we found robust RFP expression in approximately 10% of all DRG neurons 
which corresponded to the ~8% of cells which expressed TrkB mRNA (Fig 4).  
 
Figure 4: Expression of TrkB in DRG 
Expression of RFP and TrkB-mRNA in DRG sections and quantification of the number of TrkB+ 
DRG 
 
 
We next co-labelled neurons with known markers of sensory neurons and found that majority of 
TrkB+ neurons co-expressed NF200, a marker for myelinated sensory neurons (Fig 5a). We also 
found a small proportion of TrkB+ neurons (~40%) to co-expresses Ret, a marker for a subset of 
rapidly adapting LTMR’s (Fig 5b).  
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However, all TrkB+ neurons were negative for Isolectin B4; a marker for non-peptidergic 
nociceptors, CGRP; a marker for peptidergic nociceptors and TH, a marker for C-fiber LTMR’s 
(Fig 5c-e, 11a). 
4.1.2 TrkB expression in the skin 
The peripheral afferents of TrkB+ neurons in the skin were labelled by generating 
TrkBCreERT2::Rosa26SnapCaaX mice, making use of the Snap-tag technology which uses a site 
specific binding of O(6)-benzylguanine (BG)-modified molecules to a Snap-tag protein (Yang et 
al., 2015). Using this line, we found TrkB+ afferents in the hairy skin where they formed 
lanceolate endings on hair follicles (Fig 6). 
 
 
Figure 5: Co-localization of TrkB with known molecular markers 
Double immunofluorescence of sections of DRG from TrkBCreERT2::Rosa26RFP mice with markers 
(a) NF200, (b) Ret, visualized using TrkBCreERT2::Rosa26RFP::RetEGFP triple transgenic mice, (c) 
IB4, (d) CGRP, and (e) TH. Scale bar 50mm 
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Interestingly, we also found TrkB expressing afferents in the glabrous skin where they 
innervated specialized end organs called Meissner’s corpuscles which detect gentle pressure 
applied to the surface of the skin (Fig 7). 
 
Figure 6: TrkB innervates hair follicles in the skin 
Cross-section of the back hairy skin showing TrkB+ lanceolate endings of TrkBCreERT2::Rosa26SnapCaaX 
mice labeled with Snap Cell TMRstar (red), NF200 (green) and DAPI (blue). Scale bar 40mm. 
 
 
 
 
Figure 7: TrkB innervates Meissner’s corpuscles in glabrous skin 
Section from the hind-paw of TrkBCreERT2::Rosa26ChR2YFP (red) stained with anti-S100 a marker for 
Meissner’s corpuscles (green) and DAPI (blue). Scale bar 40mm.  
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4.1.3 TrkB expression in the spinal cord 
We next examined the central projections of TrkB neurons in the spinal cord by 
generating a reporter line in which Cre dependent expression of mCherry was driven from the 
sensory neuron specific Avil locus (Supplementary Fig.). TrkBCreERT2::AvilmCherry positive 
afferents were present in laminae III/IV of the dorsal horn of the spinal cord where they formed 
columnar structures extending dorsally (Fig 8).  
 
4.1.4 TrkB expression in human DRG and skin 
We also examined the expression of TrkB in human tissues using an antibody against TrkB 
(TrkB-IR). In DRG’s, all TrkB-IR observed were NF200+ (Fig 9a), with some TrkB-IR being 
Ret+ (Fig 9b). All TrkB-IR cells were negative for TrkA (Fig 9c) which was used as a marker for 
nociceptors. In accordance with the mouse data, TrkB-IR was also found innervating the 
Meissner’s corpuscles in the palmar skin (Fig 10). Together, these results suggest that TrkB 
marks a population of mechanoreceptors.  
 
Figure 8: TrkB terminates in laminae III/IV of the dorsal horn 
Section through the dorsal horn of the lumbar spinal cord of TrkBCreERT2::AvilmCherry mice 
stained with IB4, a marker for lamina II shows TrkB+ afferents in laminae III/IV. Scale bar 
50mm. 
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Figure 9: TrkB-IR in human DRG marks mechanoreceptors 
Double immunofluorescence of human DRG sections stained with antibodies against TrkB and (a) NF200, 
(b) Ret and (c) TrkA showing TrkB-IR colocalization with NF200 and Ret but not TrkA. Scale bar 40mm. 
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Figure 10: TrkB-IR in Meissner’s corpuscles of human palmar skin 
Cross-section of the human glabrous skin from the palmar region stained with antibodies against 
TrkB (red) and NF200 (green), and DAPI (blue). Scale bar 40mm. 
 
4.1.5 Ex-vivo skin nerve electrophysiology 
To establish the identity of TrkB+ sensory neurons, we characterized their response 
properties by combining skin-nerve electrophysiology and optogenetic activation. Mice 
expressing the light-gated ion channel channelrhodopsin (Rosa26ChR2) in TrkB+ neurons were 
generated (TrkBCreERT2::Rosa26ChR2) and functionally characterized based on the conduction 
velocities, firing patterns and the lowest force required to generate action potentials (Fig 11b-c). 
Photostimulation of the skin of the TrkBCreERT2:: Rosa26ChR2-EYFP mice with blue light (470nm) 
evoked action potentials in two different fiber types; D-hairs (as characterized by conduction 
velocities in the range of 2-10 m/s) and RA Ab-LTMR’s or RAM’s (>15 m/s) while other 
populations were irresponsive to light (Fig 11d). These fibers also exhibited very fine mechanical 
thresholds (<0.1g) upon probing the skin with graded von-Frey filaments (fig 8j).  
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These experiments taken together with the histological characterization confirm that TrkB is 
expressed in myelinated neurons that innervate hair follicles and are tuned to detect gentle 
mechanical stimuli.  
Figure 11: Skin-nerve electrophysiology of TrkB+ afferents 
Quantification of staining on mouse DRG sections (a). In-vitro skin nerve preparation from 
TrkBCreERT2::Rosa26ChR2 mice showing (b) the minimum force required to activate the indicated 
fiber type, (c) the conduction velocities of the fiber types and (d) responses to 10Hz stimulation 
with blue light. Red bar represents TrkB+ afferents (n=10). Error bars represent SEM. Data 
generated by Dr. Francisco Taberner.  
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4.2 Functional characterization of TrkB+ neurons 
4.2.1 Ablation of TrkB+ neurons leads to reduction in responses to gentle touch 
Next, to determine the function of TrkB+ D-hairs and RAM’s in the behavior of adult 
mice, we genetically ablated TrkB neurons in the peripheral nervous system using a Cre-
dependent diphtheria toxin receptor (iDTR), knocked-in to the sensory neuron specific Advilin 
locus. This line facilitates the deletion of TrkB+ neurons only within the DRG without affecting 
other tissues (Stantcheva et al., 2016). Upon systemic injection of diphtheria toxin in 
TrkBCreERT2::AviliDTR mice, we achieved a >90% ablation of TrkB+ neurons (Fig 12a-c). Also, we 
noticed a reduction in the number of NF200+ neurons by ~40% with no change in the expression 
of other markers such as Isolectin B4, CGRP or TH (Fig 12c).  
TrkBCreERT2::AviliDTR mice were then subjected to a series of behavioral tests to examine their 
sensory deficits. Ablated mice showed normal responses to evaporative cooling of the hind-paw 
evoked by acetone (Fig 12d), or in latency to respond to noxious heat (Fig 12e). Similarly, 
responses to noxious pinprick remained unaltered by ablation (Fig 12g).  We also noticed that the 
grip strength (Fig 12f) and the ability to detect and remove a small piece of tape stuck to the back 
(Fig 12h) remained unaffected after ablation of TrkB+ neurons.  
We tested responses to dynamic mechanical stimulation of the skin by brushing the plantar 
surface of paw using a ‘puffed out’ cotton swab which exerts forces in the range 0.7-1.6mN. We 
observed a significant reduction in responsiveness upon ablation of TrkB+ neurons (Fig 12i). 
These differences, however, were not apparent upon brushing using a stronger force elicited by a 
paint brush (>4mN, Fig). These results suggest that under baseline conditions, TrkB+ sensory 
neurons are required for detecting the lightest of mechanical stimuli acting on the skin.  
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Figure 12: Diphtheria toxin mediated ablation of TrkB+ neurons 
Immunofluorescence of DRG sections from TrkBCreERT2::AviliDTR mice with an antibody against 
the diphtheria toxin receptor (red) in (a) untreated mice and (b) after ablation. (c) Quantification 
of DRG sections indicating a ~90% decrease in TrkBDTR and TrkBmRNA cells after ablation and 
~40% reduction in NF200+ neurons without affecting other subpopulations. Behavioral responses 
in littermate control mice (AviliDTR ,black bars) and TrkBCreERT2::AviliDTR mice (white bars); no 
differences in responses upon ablation in (d) acetone drop test (t-test; p>0.05), (e) hot plate test 
(t-test; p>0.05), (f) grip test (t-test; p>0.05), (g) pin-prick test (t-test; p>0.05), (h) tape test (t-test; 
p>0.05). (i) Ablated mice shows reduction in responses to cotton swab (t-test, p<0.001). Scale 
bars in A, B 50μm, error bars indicate SEM. 
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4.3 Role in mechanical allodynia 
As mentioned earlier, previous studies have implicated myelinated LTMR’s in mechanical 
allodynia. However, the identities of neurons that drive this condition have remained poorly 
understood. Taking into account, the sensitivity of TrkB+ neurons, we next asked whether they 
contribute to mechanical hypersensitivity in mouse models of neuropathic pain. To this end, we 
took both a loss of function and a gain of function approach using approach using genetic 
ablation and optogenetic activation of TrkB neurons respectively. 
4.3.1 Inflammatory pain unaffected in TrkB ablated mice 
Neuropathic pain can manifest as mechanical hypersensitivity to inflammation of the skin 
or to a nerve injury.  We first considered the inflammatory model of neuropathic pain by 
injecting Complete Freund’s Adjuvant (CFA) into the plantar surface of the hind-paw and 
recording responses to punctate von-Frey filaments and dynamic brush stimuli. Ablation of 
TrkB+ neurons in TrkBCreERT2::AviliDTR mice had no effect on the mechanical hypersensitivity 
after inflammation (Fig 13a-b). We next examined whether optogenetic activation of TrkB 
neurons could evoke pain under inflammatory conditions. Using stimulation parameters which 
evoked robust firing in the ex-vivo skin nerve preparation, we observed no differences in 
behavioral response to light application to the hind-paw either in basal conditions or after 
inflammation in TrkBCreERT2::Rosa26ChR2 mice (Fig 13c). 
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Figure 13: TrkB+ neurons drive mechanical allodynia 
Mechanical allodynia in both control AviliDTR (black bar) and TrkBCreERT2::AviliDTR (white bar) mice 48 
hours after CFA injections as measured by (a) von Frey filaments (t-test, p>0.05) and (b) dynamic brush 
stimuli (t-test; p>0.05). All mice received diphtheria toxin injections. (c) Paw withdrawal frequencies in 
contralateral (black bar) and CFA injected ipsilateral (white bar) paw of TrkBCreERT2::Rosa26ChR2 mice 
upon stimulation with 473nm blue light shows no significant difference under baseline conditions and 
48 hours after CFA injection (Mann-Whitney test; p>0.05). (d) Mechanical thresholds to von Frey 
filaments indicating that ablation of TrkB+ neurons abolished the development of mechanical allodynia 
after SNI in TrkBCreERT2::AviliDTR mice (white circles) in comparison to AviliDTR controls (black circles) 
(n=7 for both sets, Two-way RM ANOVA; p<0.001 followed by a Bonferroni post-hoc test). (e) 
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4.3.2 TrkB+ neurons contribute to allodynia after nerve injury 
We next induced neuropathic pain in mice using the Spared Nerve Injury (SNI) model 
wherein two of the three branches of the sciatic nerve are ligated together and cut leaving the 
sural nerve intact. This allows for testing the hypersensitivity of the intact sural nerve innervating 
areas of the hind paw. Using this well-established model, we found that control mice developed a 
strong mechanical hypersensitivity in the sural nerve territory of the hind-paw to both von-Frey 
filaments and dynamic brush stimuli after injury. Strikingly however, upon ablation of TrkB+ 
sensory neurons, mice failed to develop mechanical allodynia to both punctate and dynamic 
stimuli, and mechanical thresholds remained at preinjury levels throughout the experimental 
period (Fig 13d-e). 
We subsequently activated TrkB+ afferents in TrkBCreERT2::Rosa26ChR2-EYFP mice using 
optogenetics and found that photostimulation of the hind-paw induced prolonged paw 
withdrawal and pain-like behavior (flicking and licking) of the injured ipsilateral paw starting 
from 3 days after injury and persisted throughout the testing period (Fig 13f). This behavior was 
not observed in the uninjured contralateral paw or in control littermates. 
Taken together these results suggest that TrkB+ neurons are required for the induction and 
maintenance of nerve injury driven mechanical allodynia. 
Reduced dynamic brush allodynia in ablated TrkBCreERT2::AviliDTR mice (white bar) as compared to 
littermate controls (black bar; t-test p<0.05). (f) Nocifensive behavior evoked by optogenetic stimulation 
of ipsilateral (black bars) and contralateral (white bar) paw of TrkBCreERT2::Rosa26ChR2 mice after SNI 
(Two-way RM ANOVA; p<0.001). (g-h) Cross section of the lumbar spinal cord from 
TrkBCreERT2::Rosa26ChR2 mice labelled for c-fos after 1 minute exposure to a 15Hz blue light 7 days post 
SNI (g) Represents the contralateral uninjured and (h) the injured ipsilateral dorsal horn. (i) Shows 
quantification of the number of c-fos positive cells in each lamina of the lumbar spinal cord within a 
40μm section (black bar contralateral, white bar ipsilateral). Scale bars in G and H, 40μm. Error bars 
indicate SEM. 
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4.3.3 c-fos induction increases in lamina I after SNI 
Much of the new evidence links the mechanism of neuropathic pain to a disinhibition of 
interneurons in the spinal cord dorsal horn thereby granting LTMR afferents direct access to pain 
circuits. To test this idea we looked into induction of the immediate early gene C-fos in the 
dorsal horn of the spinal cord. Optogenetic stimulation of the paw of naïve 
TrkBCreERT2::Rosa26ChR2 mice resulted in C-fos immunoreactivity primarily in laminae III and IV 
of the spinal cord, the region where TrkB afferents terminate (Fig 13g,i). However, upon nerve 
injury, identical stimulation of the paw induced an increased C-fos staining in lamina I of the 
dorsal horn, an area associated with nociceptive processing (Fig 13h,i).  
Thus, TrkB+ sensory neurons are necessary and sufficient to transmit gentle touch signals that 
evoke pain under pathological conditions. 
4.4 BDNFSNAP as a target for TrkB+ neurons 
Treatment of allodynia has been clinically challenging with current treatment, involving 
the use of conventional analgesics and opioids like morphine, being often ineffective. This has 
been largely attributed to the lack of understanding of the circuitry involved in neuropathic pain. 
In light of the clinical importance of mechanical allodynia in neuropathic pain patients, we 
developed a pharmacological strategy to target TrkB+ neurons which provoke this pain state. 
TrkB receptor signals through binding to ligands, Brain Derived Neurotrophic Factor (BDNF) or 
Neurotrophin-4 (NT4). With bulk of the evidence pointing to BDNF being the most common 
ligand of TrkB, we produced a recombinant BDNF protein with a Snap-Tag fused to its c-
terminus. The recombinant protein was produced in CHO cells and purified by the Protein 
expression facility in EPFL, Lausanne.  
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4.4.1 BDNFSNAP labels TrkB+ neurons in-vitro 
BDNFSNAP was coupled to a fluorescent Snap-Surface647 substrate and applied in-vitro 
to HEK293T cells expressing neurotrophin receptors (TrkA, TrkB or TrkC along with p75NTR). 
Fluorescently labelled BDNFSNAP displayed strong co-localization with TrkB/p75 (Fig 14a), and 
did not bind to cells expressing other neurotrophin receptors TrkA/p75 (Fig 14b) or TrkC/p75 
(Fig 14c).  
Next to test whether BDNFSNAP recognizes TrkB receptors in DRG neurons, we conjugated 7nM 
of BDNFSNAP to Qdot 655 quantum dots in an equimolar ratio and applied the mixture on to 
dissociated DRG neurons from TrkBCreERT2::Rosa26RFP mice. We observed a >95% overlap 
between BDNFSNAP and TrkB+ neurons (Fig 14d) indicating that recombinant BDNFSNAP is 
highly selective to TrkB neurons. 
 
Figure 14: BDNFSNAP labelling on cells in-vitro 
HEK293T cells labelled with BDNFSNAP upon transfection with (a) TrkB/p75NTR, (b) 
TrkA/p75NTR, or (c) TrkC/p75NTR. (d) Labeling and quantification of dissociated DRG 
(inset) from TrkBCreERT2::Rosa26RFP mice with BDNFSNAP shows significant overlap of 
BDNFSNAP binding to TrkB+ cells. Scale bars 20mm. 
 
4.4.2 BDNFSNAP mediated ablation in-vitro 
In order to manipulate TrkB neurons, BDNFSNAP was conjugated to a benzylguanine 
modified derivative of the highly potent near-infrared photosensitizer IRDye®700DX 
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phthalocyanine (IR700). In the first set of experiments, BDNFSNAP-IR700 coupled mixture was 
applied on to HEK293T cells expressing TrkB/p75 and cell death was assayed following near 
infrared illumination. Cells expressing TrkB/p75 showed substantial cell death 24 hours after 
light exposure (Fig 15a) that was not evident upon mock transfection or treatment with IR700 
alone (Fig 15b,c).  
 
Figure 15: BDNFSNAP mediated ablation in-vitro  
HEK293T cells transfected with TrkB/p75NTR and stained with propidium iodide 24 hours after 
treatment with BDNFSNAP-IR700 and near infrared exposure (a). BDNFSNAP mock transfected 
HEK293T cells stained with propidium iodide 24 hours after photoablation (b). Staining of 
HEK293T cells transfected with TrkB/p75NTR with propidium iodide 24 hours after treatment 
with IR700 alone and near infrared illumination (c). Scale bars 50µm. 
 
4.4.3 BDNFSNAP mediated ablation in-vivo 
We next injected 5mM BDNFSNAP-IR700 into the paw of TrkBCreERT2::Rosa26SnapCaaX 
mice followed by exposure to near infrared laser at 120-150J/cm2, 15-20 minutes after injection. 
This procedure was performed for 3 consecutive days. Sections of the skin from these mice 
displayed extensive loss of TrkB+ lanceolate endings around hair follicles and fibers innervating 
Meissner’s corpuscles in the Glabrous skin (Fig 19a), while no reduction in innervation was seen 
in control skin sections injected with unconjugated IR700 and exposure to light (Fig 19b).  
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We further investigated whether this loss of TrkB+ afferents was a result of death of TrkB+ 
neurons in the DRG. We observed no difference in the proportion of TrkB+ neurons 7 days after 
photoablation (Fig 16a-b) indicating that the loss of fibers in the skin reflects local retraction 
from their peripheral targets.  
 
Figure 16: BDNFSNAP mediated ablation in DRG sections 
Quantification of the proportion of hair follicle innervation and DRG neurons positive for TrkB 
following photoablation in the paw of TrkBCreERT2::Rosa26RFP mice. Scale bar 40mm. 
  
We also subjected mice to a series of behavioral tests and found no differences in their responses 
to noxious stimuli such as heat, cold and pin-prick after BDNFSNAP-IR700 mediated ablation (Fig 
17a-c). Surprisingly, the sensitivity of mice to cotton swab also remained unaffected (Fig 17d) 
probably due to the small area of ablation and the compensatory effects of intact TrkB afferents.  
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Figure 17: BDNFSNAP mediated ablation in-vivo  
BDNFSNAP-IR700 mediated photoablation in the paw does not affect baseline sensory 
behavior responses to (a) hot plate test (t-test; p>0.05), (b) acetone drop test (t-test; 
p>0.05), (c) pin-prick test (t-test; p>0.05) and (d) cotton swab test (t-test; p>0.05). Error 
bars indicate SEM 
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4.4.4 BDNFSNAP mediated rescue of mechanical allodynia 
Having confirmed the specificity of BDNFSNAP to TrkB+ neurons, we assessed the 
behavioral effects of BDNFSNAP-IR700 mediated photoablation on injury induced 
hypersensitivity. To do this, we first induced neuropathic pain in wildtype C57BL6 mice using 
the SNI model.  
 
Upon development of robust mechanical allodynia, the injured paw of mice was injected with 
BDNFSNAP-IR700 and illuminated with near infrared light for 3 consecutive days and we 
 
Figure 18: Photoablation using BDNFSNAP rescues mechanical allodynia 
BDNFSNAP-IR700 mediated photoablation of the hind-paw of SNI mice results in a dose specific 
reversal of mechanical allodynia, tested with von Frey filaments (a) (n=10 or 5, two-way RM 
ANOVA; p<0.05 followed by a Bonferroni post-hoc test) and dynamic brush stimuli (b) (t-test; 
p<0.05). 
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observed that starting from 3 days after final photo-ablation, mice showed a significant increase 
in pain thresholds to both punctate von-Frey filaments and to dynamic brush compared to control 
mice leading to recovery from mechanical allodynia (Fig 18a-b) which lasted for 2 weeks before 
reappearance of allodynia. This recovery trend was observed under various different 
concentrations of BDNFSNAP-IR700 coupling and light dosage conditions satisfying robustness 
of the system (Fig 18a-b).  
To ask if the recovery from allodynia and its subsequent reappearance is due to the 
retraction and re-innervation of TrkB+ afferents in the skin, photo-ablated hindpaws of 
TrkBCreERT2::Rosa26SnapCaaX mice were labelled with TMR-star BG substrate at different time 
points in the course of the experiment. 7 days after photo-ablation, when the recovery from 
allodynia was at its peak, we observed no TrkB+ afferents in the skin, which reappeared after 25 
days of photo-ablation (Fig 19a-c) corresponding to the behavioral results.    
 
Figure 19: Visualization of BDNFSNAP mediated ablation in-vivo  
Loss of TrkB+ afferents (red), but presence of other fibers (green) upon BDNFSNAP-IR700 
mediated photoablation. (a) Innervation of paw hairy skin before ablation, arrows shows 
lanceolate endings. (b) Loss of TrkB+ afferents after ablation, arrows shows PGP9.5 fibers. Note 
the absence of TrkB+ fibers (red) but PGP9.5 positive circumferential and longitudinal lanceolate 
endings (green). (c) Reinnervation of skin by TrkB+ afferents at 24 days post ablation. 
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To test the efficiency of BDNFSNAP mediated photoablation to reduce mechanical allodynia and 
to increase its translational research potential, we followed up with 2 independent models of 
neuropathic pain; Diabetic neuropathy and chemotherapy induced neuropathic pain. 
4.4.5 BDNFSNAP mediated rescue of diabetic peripheral neuropathy 
In the first model, mice were induced with diabetes by systemic injection of a single high 
dose (SHD) of Streptozotocin (STZ, 180mg/kg). 1 week after STZ injection, mice developed 
hyperglycemia which was frequently monitored by measuring blood-glucose levels using 
ACCU-CHEK glucose sticks and a conventional glucometer. Mice with blood-glucose levels 
above 300mg/dL were considered diabetic. The blood-glucose levels were maintained between 
350-400mg/dL by administration of insulin once a week. The SHD-STZ model is well known to 
produce early neuropathic pain and indeed 3-4 weeks after STZ injection, mice developed robust 
bilateral mechanical allodynia as measured by von-Frey filaments. The left hindpaw of diabetic 
mice were then injected with BDNFSNAP-IR700 and illuminated with near infrared light 
following the same protocol as before. 3 days following the photo-ablation paradigm, mice 
started showing signs of rescue from allodynia which lasted 17 days before allodynia phenotype 
reemerged (Fig 20a).  
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Figure 20: BDNFSNAP mediated rescue of diabetic and chemotherapy induced neuropathy 
BDNFSNAP-IR700 mediated photoablation rescues mechanical allodynia in (a) streptozotocin 
(STZ) model of diabetic neuropathy (n=5, two-way RM ANOVA; p<0.05 followed by a 
Bonferroni post-hoc test. Open circles; 5µM BDNFSNAP-IR700 at 200J/cm2, closed circles, 5µM 
IR700 at 200J/cm2) and (b) paclitaxel (PTX) model of chemotherapy induced neuropathy (n=5, 
two-way RM ANOVA; p<0.05 followed by a Bonferroni post-hoc test. Open circles; 5µM 
BDNFSNAP-IR700 at 200J/cm2, closed circles, 5µM IR700 at 200J/cm2). 
 
 
4.4.6 BDNFSNAP mediated rescue of chemotherapy induced neuropathic pain  
In the second model, to mimic chemotherapy induced neuropathic pain, wildtype C57BL6 
mice were injected systemically with Paclitaxel for 4 alternate days. As reported by earlier 
studies, mice develop long lasting bilateral allodynia 1 week after the final injection. Upon 
development of allodynia, the left hindpaw was photo-ablated using BDNFSNAP-IR700 as 
mentioned before. Similar to the previous models, this treatment led to the recovery from 
allodynia starting from 3 days after photo-ablation and lasted for 22 days (Fig 20b). 
 
 
76 
 
5 Discussion 
The sensory neurons of the DRG form a complex circuit between end organs in the skin and 
different laminae of the spinal cord where the signals are processed and transmitted to different 
brain regions (Abraira and Ginty, 2013). Injury or nerve damage causes an imbalance in this 
circuitry leading to neuropathic pain. Our knowledge on how the signals are processed under 
conditions of injury have been very limited owing to the heterogeneity of sensory afferents and 
the lack of molecular tools to investigate this condition. In this study, using an inducible Cre line 
(Feil et al., 2009) to mark a population of mechanoreceptors (TrkB) we show that, TrkB+ 
neurons mark D-hairs and Ab-RA LTMR’s in mice and histologically exhibit similar features in 
humans. We also show that DRG specific ablation of TrkB abolishes the development of 
mechanical allodynia after injury while specific activation of this subpopulation using 
channelrhodopsin produces nocifensive behavior after injury. Furthermore, we develop a novel 
technology to deliver phototoxic dye to TrkB afferents in the skin to reverse mechanical 
allodynia in different neuropathic pain states.  
5.1 TrkB is expressed in LTMR subsets 
The sensory neurons within the DRG form a heterogeneous mixture with different 
physiological properties. Developmental studies have shown that almost all DRG neurons 
express one or a combination of receptor tyrosine kinases, mainly TrkA, TrkB, TrkC and Ret 
(Lallemend and Ernfors, 2012). The advent of genetic manipulation techniques has facilitated the 
study of the molecular and functional characteristics of these neurons individually (Li et al., 
2011). In this aspect, one of the least understood subset is the TrkB+ neurons in the DRG. So in 
order to elucidate the stimulus-response properties of these neurons, the Heppenstall lab had 
generated a TrkBCreERT2 mouse line. TrkBCreERT2 was found to be expressed in ~10% of all DRG 
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neurons and co-labelled a common marker of myelinated mechanoreceptors; NF200 and 
interestingly 40% of all TrkB+ neurons also co-expressed Ret, a marker for a subset of 
myelinated Ab-mechanoreceptor (Luo et al., 2009). Analysis on the peripheral and central 
projections of TrkB afferents revealed features of mechanoreceptors including labelling of 
lanceolate endings on hair follicles, innervations of Meissner’s corpuscles on the glabrous skin 
and terminations within laminae III/IV of the dorsal horn of the spinal cord. Moreover, using an 
ex-vivo skin nerve preparation coupled to optogenetic activation of TrkB afferents, we show that 
TrkB marks all Ad-LTMR’s (also known as D-hairs) and RA Ab-LTMR’s. Our results in 
accordance with previous studies (Li et al., 2011, Wende et al., 2012b) establish that TrkB+ 
neurons are indeed myelinated LTMR’s. 
We also extrapolated on these results to test the expression of TrkB in human tissues. Staining 
human DRG sections with an antibody against TrkB and other neurochemical markers revealed 
that all TrkB neurons also co-expressed NF200 and a reasonable fraction of cells were also Ret+. 
Similarly, staining of TrkB on the glabrous skin obtained from the palm labelled Meissner’s 
corpuscles. Since very little co-localization was seen with nociceptive markers in the DRG and 
skin, we can deduce that the histological profile of TrkB+ neurons is the same in mice and 
humans. But due to inaccessibility to hairy skin, the labeling of TrkB in human hair follicles 
remains elusive.  
5.2 TrkB+ neurons are required to detect gentle mechanical stimuli 
Microneurography and electrophysiological experiments in rodents, primates and humans 
show mechanoreceptors innervating different end organs in the skin to perform varied functions. 
While hairy skin mechanoreceptors detect movement of hair by brushing or a gentle breeze 
across the skin, glabrous skin mechanoreceptors perform more unique tactile functions 
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depending on the end-organs (Brown and Iggo, 1967). In contrast to testing pain in mice, 
inadequate methods to assay gentle touch have hampered progress in understanding tactile acuity 
of these structures in the skin. In our study, using established behavior tests, evaluation of the 
sensory deficits in TrkBCreERT2 mice upon DRG specific ablation of TrkB neurons using 
Diphtheria toxin receptor driven from the Advilin locus (Stantcheva et al., 2016), revealed no 
differences in responses to noxious heat or cold and pricking of the paw using a pin. Our results 
also show that ablated mice exhibited no difference in awareness to a tape stuck on the back of 
the neck or in their ability to grip onto a grid. However, a reduction in the ability of ablated mice 
to respond to brushing of the hind-paw with a ‘puffed-out’ cotton swab suggested the role of 
TrkB+ neurons in detecting light mechanical force. This was in agreement with the 
electrophysiological recordings from the skin which required very low von Frey filaments to 
activate TrkB+ afferents. The ‘cotton-swab’ test however is considered arbitrary in many cases as 
the exact force acting on the skin can vary between trials. Since using a heavier set of bristles 
produced a paw withdrawal response in both sets of mice, we are forced to hypothesize that the 
force applied by the cotton-swab are fine enough to not be recognized in TrkB ablated mice. In 
the above mentioned experiments, most of the behavior tests (baring the tape-test) have been 
limited to the plantar side of the hind-paw. One question that pertains is the role of TrkB+ 
neurons innervating the hair. It was suggested as early as the 1940’s that the slightest movement 
using a cotton-bristle which represents sensations of tickle or gentle blowing of air within a 
receptive field were enough to activate D-hairs (Zotterman, 1939). Recently, using in-vivo 
electrophysiology and single hair manipulation techniques, Ginty and colleagues showed that D-
hairs are sensitive to deflection in the caudal-to-rostral direction due to the concentration of 
TrkB+ innervations in the caudal side of the hair (Rutlin et al., 2014). In lieu of these 
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experiments, we performed optogenetic stimulation of the back skin. Blue-light stimulation of 
the nape of the neck or the border of the ear using excitation parameters that produced robust 
action potential firing in skin-nerve experiments elicited a flicking of the ears or the head. This 
behavior was different from previously described wiping or itching in response to pain (Wilson 
et al., 2011). More detailed investigation into this behavior and better tests would be necessary to 
dissect out the exact role of TrkB+ neurons in behaving mice under naïve conditions.  
5.3 TrkB+ neurons drive mechanical allodynia after injury 
The molecular and functional characteristics of TrkB+ neurons along with several lines of 
evidence indicating a role for myelinated mechanoreceptors in mediating allodynia, makes this 
subset of neurons a key candidate in neuropathic pain. In the first set of experiments, using CFA 
induced inflammation of the skin we found that ablation of TrkB+ neurons had no effect on the 
development of allodynia or primary hyperalgesia. Similarly, channelrhodopsin mediated 
activation of the injured hind-paw did not result in any pain like behavior in mice. Detailed 
studies on different models of neuropathic pain (as mentioned in 2.8.5) place the SNI model as 
the closest reflection of clinical states as the inflammatory component left behind after injury is 
bare minimal (Pertin et al., 2012). So utilizing the SNI model, in a second approach we show that 
ablation of TrkB+ neurons abolished the development of mechanical allodynia to both punctate 
and dynamic mechanical stimuli after injury. This suggests a role for TrkB+ neurons in 
maintaining allodynia states. In an attempt to understand if these neurons are solely required to 
maintain allodynia or can directly transmit pain after injury, we tested optogenetic activation of 
the hind-paw of TrkBCreERT2::Rosa26Chr2 mice. Surprisingly, blue-light activation of the injured 
hind-paw resulted in strong nocifensive behavior as visualized by prolonged paw withdrawal, 
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flicking and licking of the paw. Taken together our results confirm that TrkB+ neurons are 
necessary and sufficient to drive allodynia after nerve injury.  
Two keys questions arise from our findings:  
1. What is the mechanism behind touch sensing neurons transmitting pain after an injury? 
Or in other words what is the mechanism of mechanical allodynia? 
2. Having found the population of mechano-sensory neurons mediating allodynia, would 
selective targeting of these neurons hold the key to the rescue of pain? 
There is general acceptance in the field that allodynia is a result of changes within the dorsal 
horn of the spinal cord in which myelinated LTMR’s which terminate in Lamina III/IV gain 
access to pain projection neurons in lamina I. It was initially proposed that this phenomenon was 
due to sprouting of Ab and Ad-LTMR afferents from lamina III into lamina II two weeks after 
peripheral nerve injury (Woolf et al., 1992). This was contradicted by others claiming that the 
method used by Woolf et al., also labels C-fibers following nerve damage (Mannion et al., 
1996). It is now believed to materialize through a complex disinhibition of interneurons within 
laminae III/IV (Duan et al., 2014, Foster et al., 2015, Peirs et al., 2015). Therefore using c-fos 
labelling in the spinal cord we followed up on this theory. Optogenetic activation of TrkB+ 
afferents in the hind-paw of naïve mice induced c-fos activity in lamina III/IV. Interestingly, 
similar activation of injured hind-paw produced increased c-fos labeling within lamina I. 
Understanding the mechanism of inhibition and the interneurons involved would require further 
investigation. 
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5.4 BDNFSNAP as a therapeutic molecule for allodynia in mice 
One of the common approaches to reduce neuropathic pain is the use of anti-inflammatory 
drugs such as aspirin or ibuprofen. More complex neuropathic pain states have heavily relied on 
the analgesic effects of opioids (like morphine and oxycodone), cannabinoids and tricyclic 
antidepressants (TCA) (Attal and Bouhassira, 2015, Dworkin et al., 2010). These drugs have 
limited effectiveness and larger side-effects with less than 50% of patients benefitting from 
medication. The cutaneous receptors in the skin have been the testing ground for several 
therapeutic targets. Three particularly interesting studies influenced our next approach of 
blocking pain at the periphery. 
1. Development of monoclonal anti-NGF antibodies (Tanezumab) on the basis that NGF 
and its receptor TrkA play important roles in several chronic pain states such as 
osteoarthritis, lower back pain etc., supported by evidence of pain insensitivity in patients 
with specific mutations in genes encoding for TrkA (Hefti et al., 2006, Rittner et al., 
2008). 
2. Targeting inhibitory opsins to nociceptive neurons via viral injections to block pain in 
mice upon exposure to light (Iyer et al., 2014, Daou et al., 2016) 
3. A potential cancer therapy using near infrared photosensitizers (IR700) conjugated to 
monoclonal antibodies to human epidermal growth factor receptors (HER1/HER2) 
(Mitsunaga et al., 2011).   
Having previously found a paradoxical role for TrkB+ neurons in mechanical allodynia, we asked 
if depleting TrkB+ afferents in the skin would help in blocking mechanical allodynia. And to 
answer this question, we designed a photo-therapeutic method based on BDNF to perform ligand 
mediated laser ablation. Primary to the approach was the production of BDNFSNAP. With the help 
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of collaborators at the Protein expression facility at EPFL, Lausanne, we designed a recombinant 
BDNF tagged with a Snap-tag protein (BDNFSNAP) in an attempt to target neurons expressing 
TrkB. 
We first validated the specificity of BDNFSNAP by labelling HEK293T cells and DRG’s in-vitro. 
BDNFSNAP bound to HEK293T cells transfected with TrkB/p75 while there was no evident 
labelling in cells transfected with TrkA/p75 or TrkC/p75. Similarly in dissociated DRG neurons 
from TrkBCreERT2::Rosa26RFP mice, BDNFSNAP labelling was mainly restricted to RFP+ cells. 
Second, we made use of a modified version of a phototoxic dye (IRDye®700DX) containing a 
benzyl guanine moiety (BG-PEG11-NH2) which was made by Kai Johnsson at EPFL, Lausanne. 
BDNFSNAP was coupled to BG-IR700 and applied the mixture onto HEK293T cells and exposed 
the cells to near-infrared light. Staining the cells for propidium iodide (PI), a marker of cellular 
apoptosis, we were able to deduce that BDNFSNAP-IR700 mixture is capable of causing cellular 
death specifically in HEK293T cells over-expressing TrkB receptors.  
We were also able to achieve ablation of TrkB+ afferents in the skin following local photo-
ablation as seen by the loss of fibers in the TrkBCreERT2::Rosa26SnapCaaX mice. A deeper look into 
the skin revealed that photo-ablation causes a site specific retraction of TrkB+ fibers that 
reappear after 20-25 days. Behavior testing of mice upon photo-ablation of TrkB+ afferents 
revealed no differences in responses to noxious thermal and mechanical stimuli in comparison 
with un-ablated controls. Surprisingly, in contrast to genetic ablation using diphtheria toxin, we 
did not see a reduction in responses to brushing of the skin with a cotton swab. One plausible 
explanation to this could be the area of ablation being smaller than the region brushed resulting 
in activation of intact afferents.   
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5.5 BDNFSNAP mediated photo-ablation reverses mechanical allodynia 
The specificity of BDNFSNAP to TrkB receptors and the above established photo-ablation 
paradigm prompted us use to this technique in an attempt to alleviate mechanical allodynia. Once 
again using the SNI model of neuropathic pain, we show that photo-ablation of the injured paw 
of mice resulted in increased mechanical thresholds to both punctate and dynamic mechanical 
stimuli in a concentration and illumination specific manner. This rescue from allodynia lasted for 
two weeks before allodynia reappeared correlating with the histological findings of re-
innervations of the skin. This intrigued us to take a step forward and test the efficacy of this 
technology other clinically important models of neuropathic pain. Remarkably, we also show 
that this technology can be used to rescue allodynia arising from pain diabetic neuropathy and 
chemotherapy induced neuropathic pain. These results taken together not only identify the 
neurons that relay mechanical allodynia, but also describe a novel site specific approach to treat 
allodynia arising from different pathological conditions.  
5.6 Future perspectives 
Previously, we established that genetic ablation of TrkB+ neurons using diphtheria toxin 
affected the ability of mice to detect gentle mechanical stimulation of the paw using a cotton 
swab correlating with our electrophysiology data that the force required to activate TrkB+ 
afferents in a skin-nerve preparation is extremely low. Studies in humans and mice suggest that 
the light mechanical stimulation of the skin causes a type of itch referred to as mechanical itch. 
This behavior is seen particularly upon stimulation of vellus hairs (Fukuoka et al., 2013, Bourane 
et al., 2015). Considering the similarities between vellus hairs and D-hairs, and encouraged by 
the ‘fluttering-like’ responses to optogenetic stimulation of the back skin, we are currently 
designing a behavior paradigm to test touch evoked itching as a functional correlate of light 
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touch. A role for TrkB+ neurons in mechanical itch could potentially help preventing 
‘alloknesis’, a form of mechanical itch that accompanies chronic itch conditions and lasts much 
after its treatment. 
The molecular characterization of TrkB+ sensory neurons revealed expression in D-hairs 
and RA-Ab fibers. One of the many questions that rise from the mechanical allodynia phenotype 
is; do both the subpopulations (D-hairs and Ab-LTMR’s) contribute to allodynia? To address 
this question we plan to take two approaches to selectively ablate one of the two populations. In 
the first set of experiments we will use a NT-4-/- mice (obtained from Gary Lewin, MDC Berlin) 
in which all D-hairs are lost in adults (Stucky et al., 1998). Behavior testing for mechanical 
allodynia in these mice before and after the loss of D-hairs would help clarifying the role of Ad-
LTMR’s in neuropathic pain. In the second set of experiments, we will cross 
TrkBCreERT2::Rosa26SnapCaaX mice to RetEGFP/EGFP homozygous mice (Jain et al., 2006) to generate 
(TrkBCreERT2::Rosa26SnapCaaX::RetEGFP/EGFP) triple transgenic mice under the hypothesis that 
TrkB+/Ret+ neurons form Ab-LTMR’s (Luo et al., 2009, Bourane et al., 2009). Administration of 
tamoxifen to this line should result in condition knock-out of the Ret locus resulting in selective 
ablation of TrkB+/Ret+ neurons enabling us to evaluate the role of Ab-LTMR’s in mechanical 
allodynia.    
Throughout the thesis, the mention of central sensitization has been repeated under 
different contexts. Electrophysiological recordings by several labs across the globe using in-vivo 
and in-vitro techniques constantly find presynaptic currents from A-fiber mechanoreceptors in 
dorsal horn inhibitory interneurons. A loss in the inhibitory control following nerve injury results 
in primary afferent fibers accessing nociceptive pathways. Markers for many inhibitory 
85 
 
interneurons subtypes have been identified in recent years (Braz et al., 2012, Foster et al., 2015, 
Duan et al., 2014, Peirs et al., 2015). It is now evident from these studies that touch sensing 
neurons can synapse onto GABAergic or glycinergic inhibitory interneurons some of which can 
be marked by Dynorphin or to VGlut3+ excitatory interneurons which are under inhibitory 
control under basal conditions or to PKCg neurons. But to what extent the A-fibers regulate 
different interneurons and the identity of all interneurons that participate in allodynia is still 
uncertain. We strongly believe this can be solved using our TrkBCreERT2 mouse line. 
Monosynaptic virus tracing techniques or C-fos labelling can be used to identify the interneurons 
that receive Ad and Ab-LTMR terminations on activation of TrkB using 
TrkBCreERT2::Rosa26ChR2-YFP mice. Electrophysiological recordings on spinal cord interneurons or 
projection neurons after injury upon ablation and optogenetic/pharmaco-genetic activation of 
TrkB+ afferents would help resolve the mechanism underlying allodynia. This in combination 
with behavioral tests would help map the central circuits involved in different pathological pain 
conditions.  
Apart from spinal cord mechanisms, alteration in gene expression in injured neurons could 
be the cause for long lasting neuropathic pain. Our TrkBCreERT2 mouse line gives us a good tool 
to study the changes in gene expression in TrkB+ neurons following nerve injury. To this end we 
have setup a RNA sequencing protocol in which a small number of TrkB+ cells (5-10) are 
manually picked using a patch pipette (Fig 21), snap frozen and sent to the Genomics core 
facility in EMBL, Heidelberg for RNA sequencing. Analysis of the results from this experiment 
could shed light onto some of the peripheral and presynaptic mechanisms underlying mechanical 
allodynia.   
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Figure 21: Manual picking of cells for sequencing 
Manual picking of dissociated DRG’s from TrkBCreERT2::Rosa26SnapCaaX::RetEGFP triple transgenic 
mice. 
 
Additionally, we would also like to focus our attention in understanding the mechanism 
behind ablation using BDNFSNAP-IR700. We have shown proof of retraction and re-innervation 
of fibers following photo-ablation in TrkBCreERT2::Rosa26SnapCaaX mice. Expression of TrkB and 
BDNF has been found in non-neuronal cells including keratinocytes, mast cells, immune system 
cells etc. (Shibayama and Koizumi, 1996) and in macrophages that accompanies nerve injury or 
inflammation. Even though we do not observe dramatic behavior deficit upon ablation, it will be 
of importance to study the impact of photo-ablation of other cell types in the skin and their 
contribution to the observed phenotype especially considering the pharmaco-therapeutic 
prospects of our approach. One interesting idea to answer this issue would be to undertake in-
vivo high speed deep tissue imaging of photoablation in live skin tissues from BG-substrate 
labelled TrkBCreERT2::Rosa26SnapCaaX mice. The re-innervation of nerves after ablation posts 
potentially interesting questions: Do the nerves innervate the correct end-organs? What directs 
them into the same location? And are these afferents physiologically the same as before? We 
plan to conduct detailed histological analysis of the re-innervation and skin-nerve recordings to 
answer these questions. 
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6 Conclusion 
We have managed to find a crucial element of the somatosensory circuit involved in 
neuropathic pain and developed a new technology based on ligand mediated ablation of nerve 
fibers to rescue this pain state. 
In conclusion, 
1. TrkB is expressed in 10% of all DRG neurons and exhibit characteristics of low threshold 
mechanoreceptors, specifically D-hairs and RA Ab-fibers.  
2. DRG specific ablation of TrkB+ neurons reduces responses to gentle touch 
3. TrkB ablated mice fail to develop mechanical allodynia while activating the same induces 
pain after injury.  
4. Local photo-ablation of TrkB+ afferents using a combination of BDNFSNAP-IR700 
rescues allodynia in several neuropathic pain states 
Finally, I hope the contribution made through this work will serve useful to the scientific 
community in understanding and developing new drugs to treat some aspects of the ‘disease’ of 
neuropathic pain.  
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8 Supplementary figures 
 
Supplementary figure 22: Generation of TrkBCreERT2 and AvilmCherry-hM3DQ mice  
Genetic strategy for the generation of (a) TrkBCreERT2 BAC transgenic and (b) AvilmCherry-hM3DQ 
lines. (c) Southern blot for the AvilmCherry-hM3DQ line. 
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Supplementary figure 23: in-situ hybridization for TrkB 
In-situ hybridization for TrkB mRNA in (a) control and (b) ablated mice. (c) Quantification 
of number of TrkB+ cells 
 
 
 
 
Supplementary figure 24: Staining for molecular markers on TrkB ablated mice 
Cross-section of DRG from TrkB ablated mice stained with IB4, TH and CGRP shows no 
difference in numbers on ablation.  
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Supplementary figure 25: Innervation of hind-paw after BDNFSNAP photoablation 
Schematic of the hind-paw of mice showing the (a) different analyzed regions of the glabrous 
skin under (b-e) baseline conditions, (c-f) after ablation and (d-g) upon re-innervation.   
